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Propofol is a new intravenous anaesthetic agent with rapid and superior 
recovery characteristics when compared with thiopentone. After extensive 
evaluation, it now has a significant role in adult anaesthesia. It is particularly . 
useful for day case anaesthesia and as a component of total intravenous 
anaesthesia. However, information in paediatric practice is limited and 
currently the drug is only licensed for use in patients over three years of age. 
The hypothesis of this thesis is that propofol is an effective anaesthetic agent 
for short surgical procedures in children. This thesis evaluates and compares 
the clinical pharmacology of propofol with that of thiopentone, the current 
gold standard for intravenous anaesthetic agents, in paediatric patients. 
Research Model 
It is well recognized that infants and children differ from adults in the way 
they respond to drugs. Pharmacokinetic and pharmacodynamic data are 
essential for understanding the age-related differences in disposition and for 
determining dosage regimens for newly developed drugs. The 
pharmacokinetic and pharmacodynamic studies in this thesis were carried 
out on healthy Chinese children aged between six months and 12 years old 
who required general anaesthesia for short elective surgical procedures. The 
research methods were designed to determine the pharmacokinetics of 
propofol in children and evaluate the clinical use of propofol during three 
phases of anaesthesia; induction, maintenance and recovery. 
Induction of anaesthesia 
Induction dose 
The dose of propofol required in children was determined by a quantal dose 
response study. Three hundred unpremedicated healthy children were 
divided into three age groups: less than two years, two to five years and six 
to 12 years old. E050 and E095 for loss of eyelash reflex and acceptance of 
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face mask were determined using probit analysis. The E050 and E095 for 
both the end points were largest in the group less than two years old which 
decreased with age. E095 for acceptance of face mask in the three age groups 
in ascending order were 2.88, 2.53 and 2.20 mg.kg-1 respectively. The results 
suggested that a dose of 2.5-3.5 mg.kg-1 is required for induction of 
anaesthesia in children, with the younger children needing more than the 
older ones. The induction dose required in children is larger than that 
required for adults ( 2-2.5 mg.kg. -1). 
Bolus dose pharmacokinetics 
Age-related physiological changes in the distribution of body water, hepatic 
function, and renal function affect the distribution, metabolism and excretion 
of drugs. Bolus dose pharmacokinetic variables were determined by 
studying the blood concentration profile after a dose of propofol 2.5 mg.kg-1 
in 23 children between one and 12 years old. Blood samples were taken at 2, 
4, 10, 15, 30, 45, 60, 120, 240, 360, 480, 720 minutes after administration of 
propofol. The pharmacokinetic variables were derived by both non 
compartmental analysis using statistical moment theory (NC) and by 
compartmental analysis (C). The mean central volume of distribution (Vc) 
was 0.66 (5D 0.23) l.kg-1, volume of distribution at steady state (V ss) 4.4 
(5D1.78) l.kg-1, clearance (Cl) 49.96 ml.kg.-1min -l(C) and 51.02 ml.kg.-1min 
-1 (NC), and t1/2a, t 1/2~, t 1/2y were 2.79, 24.72 and 216.48 minutes 
respectively. There was no correlation between age and the values of Vc, Vss 
and Cl. Protein binding in 22 children was compared with that in 11 adults 
and binding was similar (98.8% for children less than 3 years old, 98.60/0 for 3 
to 12 years old, and 98.4% for adults). The volume of distribution and 
clearance values appeared to be larger than those in adults (Vc 0.48 l.kg-1, 
Vss 3.541.kg-1, and Cl 28.76 ml.kg.-1min -1) reported previously. However, 




Adult studies showed that propofol causes a significant decrease in arterial 
pressure during induction of anaesthesia. This aspect was studied in depth 
in children with two studies. The arterial pressure and pulse rate changes in 
response to different doses \vere studied during the dose finding 
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investigation. A reduction in arterial pressure of 15% after one minute and 
30% after five minutes was observed. There was a 170/0 reduction in pulse 
rate. In the dose range of 1.6 to 2.6 mg.kg-1 of propofol during the induction 
dose study, noninvasive arterial pressure monitoring showed that the 
reduction in blood pressure and heart rate was not dose related. In order to 
understand the mechanism of cardiovascular depression associated with 
propofol in children, the haemodynamic responses to intravenous propofol 
2.5 mg.kg-1 were compared with those to thiopentone 5.0 mg.kg-1 in 41 
children during induction of anaesthesia. Cardiac output was measured by 
the noninvasive technique of pulsed Doppler and two-dimensional 
echocardiography. The age factor was examined by dividing the children 
into two age groups. Eighteen children were less than two years and 23 were 
between two and 12 years old. The reduction in mean arterial pressure was 
significantly greater after propofol (28-31%) than after thiopentone (14-21%) 
(p= 0.001). A reduction in both cardiac index and systemic vascular 
resistance were found to be associated with the reduction in blood pressure. 
The reduction in cardiac index (10-15%) after induction was similar with the 
two agents. Baroreflex mediated increases in heart rate and systemic 
vascular resistance were less after propofol than after thiopentone. The 
baroreflex was more attenuated in children less than two years old than in 
older children. 
Other effects 
The incidence of apnoea observed following propofol administration was 0% 
to 53% in the dose range of 1.2 to 2.6 mg.kg-1. It appeared to be dose-related. 
Pain on injection was observed in 0% to 45% of patients and was not dose 
related. Administration of lignocaine 0.2 mg.kg-1 with propofol was 
effective in reducing the incidence of pain. Spontaneous involuntary 
movements were observed in 44-55% of children. This is higher than the 
incidence reported in adults (12-37%). No other adverse reaction was 
observed during induction. 
Maintenance of anaesthesia 
The use of propofol as a component of total intravenous anaesthesia was 
tested by evaluating propofol infusion anaesthesia in 38 children. A suitable 
infusion regimen was sought by testing a published algorithm for a 
pharmacokinetic model controlled propofol infusion. A pilot study was 
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carried out on 10 children aged between four and 10 years old undergoing 
minor surgical procedures. Anaesthesia was supplemented with nitrous 
oxide and oxygen with patients breathing spontaneously. The precision was 
24.8% and bias -18.5%. The model was revised using an iterative linear least 
squares regression procedure. The revised pharmacokinetic variables were 
central volume of distribution (Vc) 432 ml.kg-1, kID 0.0967 min-1, kI2 0.1413 
min-1, kI3 0.0392 min-1, k2I 0.1092 min-1, and k3I 0.0049 min-1. This model 
was tested in another 20 children. Analgesia was provided by regional 
block. The precision was 21.5% and bias improved to -0.1 %. The mean blood 
concentration required to maintain anaesthesia was 6.6 J-lg.ml-1 (range 3.0-
11.0 J-lg.ml-1). The revised central volume was found to be 25% larger than 
the original data (343 ml.kg-l). This suggested that the children studied 
required a higher infusion rate to maintain a similar level of anaesthesia than 
previously reported data in children. This pharmacokinetic model infusion 
was used to complete the study in a total of 38 patients. The induction dose 
required was 3.5 mg.kg-1 and the mean infusion dose was 27.3 mg.kg.-1h.-1 
(range 7.6 to 44.5 mg.kg.-1h-1). Anaesthesia and recovery characteristics 
using propofol infusion were compared with three other methods of 
anaesthesia: 1) propofol induction or 2) thiopentone induction or 3) 
halothane induction, all followed by halothane, nitrous oxide and oxygen 
maintenance. Apnoea was more frequent, and the incidence of involuntary 
movements was higher in children using propofol infusion. 
Recovery 
One hundred and sixty three children were selected in the recovery study. 
The speed and quality of recovery following propofol was evaluated using 
the Steward scoring system, the time to open eyes on command and the time 
to orientation. Psychomotor testing was included to assess the recovery of 
coordination ability. Recovery was slowest with propofol infusion, 39.8 (SD 
12.9) min to open eyes on command. The recovery was significantly faster 
with the other three techniques, 21.9 (SD 9.9) min in the propofol bolus 
group, 23.4 (SD 11.3) min in the thiopentone bolus group and 20.1 (SD 8.9) 
min in the halothane group (p= 0.0001). There was no difference between 
these three methods. However, a lower incidence of vomiting was observed 
in children who had had propofol for anaesthesia. The slower recovery 
following propofol infusion was probably related to the high infusion rates 
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required and the large difference between the blood concentration required 
for anaesthesia and that at which waking occurred. 
Conclusion 
The studies in this thesis upheld the hypothesis that propofol is an effective 
induction agent. Side effects were comparable with other anaesthetic agents 
in use in paediatric anaesthesia. However, propofol by infusion to induce 
and maintain anaesthesia supplemented with nitrous oxide and regional 
block was unsatisfactory in the local Chinese paediatric population. 
Modification of the infusion and anaesthetic technique, and further 
evaluation is necessary before the place of propofol infusion in paediatric 
anaesthesia may be determined. 
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HYPOTHESIS AND OBJECTIVE 
Propofol (2,6 diisopropylphenol), was introduced to clinical anaesthesia 
in 1984 with a new emulsion formulation [Cummings et aI, 1984], and it has 
been extensively evaluated and used in adult patients [Bevan, 1993]. It has 
been shown to be a suitable alternative to thiopentone or methohexitone 
[Mackenzie and Grant, 1985a; 1985b; Valanne and Korttila, 1985; Walmsley, 
McLeod B, and Ponte J, 1985; McCollum and Dundee, 1986; O'Toole et aI, 
1987; Logan et aI, 1987; Heath et aI, 1988]. It is particularly useful for 
outpatient anaesthesia, since it provides superior operating conditions to 
methohexitone, a more rapid recovery, and a lower incidence of nausea and 
vomiting in the postoperative period [Stark et aI, 1985; Heath et aI, 1988; 
McCollum, Milligan and Dundee, 1988]. However, experience and research 
with propofol in children is still limited, and currently the drug is only 
licensed for use in children over three years of age. 
The objective of this thesis was to evaluate the use of propofol, in 
paediatric anaesthesia, the hypothesis being that propofol is an effective 
anaesthetic agent for induction and maintenance of anaesthesia for short 
surgical procedures in children. 
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REVIEW OF LITERATURE 
PAEDIATRIC ANAESTHESIA 
Evolution and development 
In the early part of this century, anaesthesia for children was 
administered by those few physician anaesthetists who had developed the 
special interest and skills needed for infants and children. It was a simple but 
hazardous "rag and bottle" type anaesthesia used mainly to control pain and 
movement [Smith, 1991]. After the second world war (1939-1945), there was 
a burst of activity in paediatric surgery. This brought a demand for 
improvement in the anaesthetic management of infants and children. It 
evolved more as an art than a science. However since the 1960s, there has 
been an explosion of knowledge of developmental physiology and 
pharmacology. This, together with the dramatic technological advancement 
in perioperative monitoring, has changed considerably the concepts and 
techniques of paediatric anaesthesia management. 
Significant recent advances in paediatric anaesthesia include 
perioperative monitoring standards, the provision of intraoperative and 
postoperative analgesia, the rediscovery of regional anaesthesia in infants 
and children, the use of newer intravenous anaesthetics, synthetic narcotics 
and shorter acting muscle relaxants in both routine and complicated cases, 
day case anaesthesia, and the presence of parents during the induction of 
anaesthesia. 
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Paediatric pharmacology research 
It is now well recognized that infants and children differ from adults in 
the way they respond to drugs. The extent of this difference was not 
appreciated until the 19605. Technical difficulties and ethical issues were the 
major obstacles to paediatric research. The development of sensitive new 
techniques in assaying drugs and their metabolites, and the advances in 
computing technology have contributed to this dramatic development in 
paediatric pharmacology [Cannon, 1987]. In the United States, the Food and 
Drug Administration has established a policy requiring that new drugs likely 
to be widely used in infants and children must be thoroughly evaluated 
before approval may be given for marketing. However there is still a 
dilemma in carrying out clinical investigations in children because of the 
potential conflict between the ethical and scientific requirements in 
paediatric research. This trend is reflected by the fact only about 25% of all 
drugs currently available on the market in North America have undergone 
adequate paediatric evaluation to be considered safe and effective [Radde 
and MacLeod, 1993d]. 
Developmental pharmacology 
Growth and maturation take place during the childhood period, 
changing the physiological factors involved in the uptake, distribution, 
metabolism, and excretion of drugs. 
The effects of intravenous drugs depend principally on the 
physiological and pharmacological processes that distribute the drugs and 
eliminate them from the body. A number of factors that influence the 
distribution of drugs are age-dependent. Most notably are the composition 
and size of "body compartments", protein binding characteristics, 
In trod uction 6 
haemodynamic factors such as cardiac output and regional blood flow and 
membrane permeability [Besunder, Reed and Blumer, 1988a; 1988b; Radde, 
1993b]. The changes in the size of various fluid compartments with growth 
have been well studied by Friis-Hansen [1961,.1971] and Widdowson [1974]. 
The body compositions at different ages are shown in Table 1.1. 
TABLE 1.1. The proportions of body compositions (in % of body weight) 
and tissue blood flow (in % of cardiac output is shown in parenthesis). 
Newborn 
Premature 
Total body water 83 
Extracellular fluid 62 
Intracellular fluid 25 





























(From Cook and Davies 1990, data from Friis-Hansen, 1971 and Widdowson, 
1974). 
Body Composition 
In the newborn and young infant, the total body water c~ntent (TBW) is 
larger (about 80% of body weight) compared with the adult (60%). The ratio 
of extracellular to intracellular water is higher than the proportion in adults 
(45: 35 vs 20: 40). The TBW, after a dramatic reduction of about 10% during 
the first few days after birth, decreases gradually. By one year of age, TBW 
has fallen to adult proportions. From this point, there is a linear relationship 
between TBW and lean body mass until old age. These changes in TBW are 
of particular relevance to water-soluble drugs. The reduction in extracellular 
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fluid (ECF) is more than the reduction in TBW, because of the increase in 
intracellular fluid (ICF). After the neonatal period, the ICF increases from 
approximately 330/0 to around the adult value of 400/0 of total body weight by 
three months postnatal age and remains steady till adulthood. The ECF 
volume is reduced to about 25% by one year of age, and 20% at puberty. The 
changes after one year are gradual. Ionized drugs tend to be confined to the 
extracellular compartment, so that changes in the relative sizes of the 
extracellular and intracellular compartments during growth will influence 
the effective concentration of ionized drugs. 
The fat store is relatively low at birth (12% of body weight) and 
increases markedly during the first year of life [Friis-Hansen, 1971], but the 
premature infant is practically devoid of fat (3% of body weight). The small 
amount of fatty tissue reduces the volume of distribution of lipophylic drugs. 
Until recently, the measurement of the adipose tissue mass and its 
development has been difficult. Earlier method used radioisotopes and 
therefore was unsuitable for children. More recent techniques have included 
absorption and desorption of nonradioactive xenon [Mettau et aI, 1977] and 
measurement of skin fold thickness [Durnin and Rahaman, 1967; Brook, 
1971]. The adipose tissue changes in size with the various stages of 
development. From 1% of total body mass at 29 weeks of gestation to 10-
15% at birth, it increases to approximately 15-30% by one year of age. With 
walking, the muscle mass develops and the adipose tissue decreases 
somewhat between one to two years of age until six years, before rising again 
at adolescence. These changes affect the distribution of lipid-soluble drugs. 
Protein binding 
Plasma protein binding of drugs influences drug distribution and 
elimination. It depends on the amount of binding proteins available, the 
affinity constant of the protein for the drug, and the presence of 
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pathophysiological conditions or endogenous substances (such as increased 
free fatty acids, bilirubin, urea) that may alter the drug protein binding 
interaction. The major proteins responsible for drug binding in plasma are 
albumin, aI-acid glycoprotein (AAG) and the lipoproteins. Most of the 
acidic drugs are bound to albumin, whereas basic drugs are bound to 
lipoproteins, (Xl-acid glycoprotein and ~ globulins. The newborn infant has a 
lower concentration of total protein, albumin and globulin than the adult 
[Boreus 1982a; Kingston et aI, 1990]. The affinity of these proteins for drugs 
may also be lower than in adults [Kurz, Michels and Stickel, 1977; Wood, 
1986]. As a result, protein binding is generally lower in young children than 
in adults. The increased free fatty acids and bilirubin in the newborn infant 
may significantly alter the drug binding to protein by competing with the 
drug for the binding sites. Hence the relationships between drug protein-
binding, free drug and the resultant drug concentration can be very 
complicated. 
Tissue blood flow 
Blood flow to various tissues is one of the factors which influence drug 
distribution in the body. The information on haemodynamic changes during 
human development has been largely extrapolated from animal data [Radde, 
1993b]. 
Following the precipitous changes of the transitional circulation at 
birth, the cardiac output is high in the neonates (150-200 ml.kg-1.min-1) 
during the first month of life [Hatch and Sumner, 1986], gradually decreasing 
to approximately 100 ml.kg-1.min-1 at adolescence [Robinson, 1983]. The 
high cardiac output during this period contributes to rapid delivery of drugs 
to the site of action. Heart rate decreases substantially during the first few 
months of life and then more gradually until adulthood with an 
accompanying increase in systemic vascular resistance (SVR). The SVR, 
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which is 800-1200 dyne.s.cm-S per square metre at birth, increases to 1600 
dyne.s.cm-S per square metre at 12-18 months after birth [Schieber, 1990]. 
The arterial pressure also gradually rises towards the adult level. 
Metabolic capacity 
Metabolism and excretion constitute the body's mechanism for 
eliminating drugs. The liver is the principal organ of drug metabolism, 
although extrahepatic sites have been shown to be capable of 
biotransforming certain drugs [Juchau and Pedersen, 1973; Bakhle, 1990]. 
The liver mass is relatively larger in infants (4% of total body weight vs 2% in 
adults) providing a theoretically larger surface area for drug metabolism 
(Table 1.1). However, the capacity for drug metabolism is low at birth. 
Newborn infants are capable of performing several steps of oxidative 
biotransformation, but glucuronide conjugations are less effective [Boreus, 
1982b]. Cytochrome P450 and nicotine adenine diphosphate hydrogenase 
(NADPH)-cytochrome-c-reductase occurred at about half of the adult 
activity [Aranda et aI, 1974]. Alternative pathways of metabolism of certain 
drugs have been demonstrated in neonates [Sereni, Morselli, and Pardi, 1973; 
BOrE~us, JaIling, and Kallberg, 1978; Choonara et aI, 1990]. After birth, there is 
a dramatic increase in efficiency of the drug metabolising system, mainly 
phase I reactions. The drug disposition rate may then increase from one fifth 
of the adult capacity to five times faster than in adults [Morselli, Franco-
Morselli, and Bossi, 1980]. This rapid elimination of drugs in children three 
months to three years of age gradually decreases to that of adults at puberty 
[Morselli, Franco-Morselli, and Bossi, 1980]. 
Renal function 
Most drugs and their metabolites are excreted by the kidney. Both 
glomerular filtration and tubular function are immature in the newborn. 
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Elimination by other routes (bile, lungs, sweat glands, faeces) is less 
substantial. 
Newborn kidneys contain essentially the same total number of 
nephrons as in adulthood. However, both glomeruli and tubules are smaller 
and in variable stages of morphological development. The glomerular 
filtration capacity is low in newborns, and increases progressively due to an 
increase in renal perfusion and a decrease in renal vascular resistance [Hook 
and Hewitt, 1977]. The glomerular filtration rate which is 30-50% of normal 
adult values at birth, approaches adult values by about six months of age 
[Boreus,1982c]. The tubular secretary function matures at a slower rate than 
that of glomerular filtration [Boreus, 1982c]. Furthermore, maturation of 
renal function during infancy and childhood affects various drugs 
differently, depending on the mode of drug handling by the kidney. 
Blood brain barrier 
A lower efficiency of the blood brain barrier has been postulated in the 
newborn infant from two observations. Firstly, newborn infants have a 
higher concentration of protein in the CSF than adults [Adinolfi et aI, 1976]. 
Secondly, animal experiments have shown that substances such as narcotics 
and dye penetrate into the eNS of the foetus and newborn more easily than 
in the adult animals [Kupferberg and Way, 1963]. However, research 
involving microscopic studies of the junctions between the endothelial and 
epithelial cells has been inconclusive [Saunders, 1977]. 
.I ~ 
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INTRAVENOUS ANAESTHESIA IN PAEDIATRICS. 
For induction of anaesthesia in children, an inhalational method is 
usually used because it is rapid, relatively safe, and it avoids injections. 
However there are instances in which an intravenous induction of 
anaesthesia is the method of choice such as for rapid sequence induction. 
Furthermore, some children find the face mask frightening, and the smell 
unpleasant. It may then be kinder to use an intravenous method using a 
small needle than it is to hold the child down and put a mask over the face of 
the struggling child. The availability of local anaesthetic cream (EMLA ® 
Astra Pharmaceuticals, Sweden) has made the intravenous injection less 
painful. EMLA is a eutectic mixture of lignocaine 25 mg.g-1 and prilocaine 
25 mg.g -1 that can produce surface anaesthesia when applied to the skin 1-
1.5 hours before the intravenous injection. In routine cases, intravenous 
induction is rapid and pleasant provided the anaesthetist is adept at the 
venepuncture of small veins. Anaesthetists, including trainees working full 
time in paediatric anaesthesia are usually quite experienced in venepuncture 
in small children [Brown, 1992]. 
,, --
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THIOPENTONE 
Thiopentone is an ultrashort acting barbiturate that produces sedation 
within one minute after intravenous administration. It was introduced in 
1934 [Lundy, 1935] and remains the most popular intravenous agent in 
children. It is the standard against which all other intravenous agents are 
compared. 
Pharmacokinetic profile 
Thiopentone has a pKa of 7.6, and therefore changes in blood pH can 
lead to significant changes in the degree of ionization of the drug. It is 60% 
unionized at normal physiological pH. Like adults, children (five months to 
13 years of age), have approximately 87% of thiopentone reversibly bound to 
plasma albumin [Sorbo, Hudson, and Loomis, 1984]. The plasma 
concentration time curve after a bolus dose of thiopentone best fits a three-
compartment model. The distribution kinetics (rapid distribution half-life of 
6.3 minutes and slow distribution of 43 minutes), volume of distribution at 
steady state Vss (2.1l.kg-1) and volume of central distribution Vc (0.41.kg-1) 
are not significantly different from those in adults. However, the elimination 
half-life is one half, the clearance (6.6 ml.kg-1.min-1) is double that of adult. 
Thiopentone has a low hepatic extraction ratio (0.1-0.16) [Gepts and Camu, 
1991] indicating that the increased clearance in children is due either to an 
increase in hepatic microsomal-enzyme activity or a relatively larger hepatic 
mass in children. The clinical implication is that children may recover 
slightly faster than adults after thiopentone administration. 
The main metabolic pathway of metabolism is by oxidation resulting in 
the production of thiopentone carboxylic acid, which is pharmacologically 
inactive. A small proportion is by desulphuration to pentobarbitone which is 
further metabolised to inactive products. The high lipid-solubility of 
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thiopentone results in extensive renal tubular reabsorption, and therefore 
minimal renal elimination of the unchanged drug. The contribution of 
metabolism to the recovery from thiopentone's anaesthetic effects has been 
recently re-examined by a pharmacokinetic characterisation of the 
distribution and elimination phases. This study confirms that the decline of 
thiopentone concentration in the brain and recovery during the first 15' 
minutes after a single intravenous dose results primarily from redistribution 
of the drug to muscle and fat tissues [Burch and Stanski, 1983]. The residual 
concentrations contribute to the long-lasting impairment in psychomotor 
skills after thiopentone [Korttila et aI, 1975]. 
Pharmacodynamic profile 
Thiopentone causes hypnosis within one arm-brain circulation time. A 
larger dose is required for induction of anaesthesia in children, 5 - 6 mg.kg-1 
for older children [Cote et aI, 1981] and 7 - 8 mg.kg-1 in infants Uonmarker et 
aI, 1987]. Neonates need less [Westrin, Jonmarker, and Wemer, 1989], and 
should not exceed 2 - 4 mg.kg-1 [Booker, 1989]. The difference in 
requirements in infants is probably pharmacokinetic and pharmacodynamic 
related Uonmarker et aI, 1987]. The desirable features of thiopentone include 
rapid onset, smoothness of action, ease of use, water solubility, painless on 
injection, and excitatory effects are uncommon. However, it has a number of 
shortcomings; its elimination is slow resulting in a slower recovery from 
anaesthesia and it is cumulative on repeated administration, it causes tissue 





Propofol is an intravenous agent, synthesized in the laboratories of ICI 
Pharmaceuticals in Macclesfield, United Kingdom. The research started in 
1973 with the aim of developing an agent that can produce rapid induction ' 
and recovery through rapid metabolism. The investigators also wanted an 
agent that could be used for both induction and maintenance of anaesthesia 
without producing side-effects. A number of substituted phenols that had 
hypnotic properties were investigated and propofol was found to be the 
agent with most potential. Unfortunately these phenolic substitutes are 
insoluble in water and therefore had to be dissolved in an organic solvent. 
The original solvent used for propofol was 16% Cremophor EL which was 
also used for Althesin (Glaxo). This was later withdrawn because of 
anaphylactic reactions associated with Cremophor EL. The Cremophor 
formulation of propofol was introduced for clinical trials in 1977 [Kay and 
Rolly, 1977]. However concern over the association of Cremophor 
containing compounds with anaphylactic reactions [Clarke et aI, 1975; Evans 
and Keogh, 1977; Glen et aI, 1979] together with high incidence of pain on 
injection in the early clinical studies [Major et aI, 1981; Briggs et aI, 1981] had 
led to the termination of clinical trials with this formulation in the late 1982. 
The drug after reformulated in an egg-oil-glycerol emulsion as a 10/0 solution, 
was available for clinical trial in 1983 [Glen and Hunter, 1984]. Propofol was 
approved for general use in the United Kingdom in 1986. 
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Chemistry 
Propofol is one of a series of alkyl phenols with a molecular structure as 
shown in Figure 1.1. Substitution at the ortho position of the parent 
compound, phenol, induces steric hindrance in the adjacent hydroxyl group, 
modifying the hydrogen bond donor-acceptance properties. This change in 
structure attenuates the protein denaturing effect and confers anaesthetic 
activity. Optimal anaesthetic activity is obtained by substitution at the 2 and 
6 positions with secondary alkyl groups so that there are a total of six to eight 
carbon atoms in the substituent chains [James and Glen, 1980]. It has a 
molecular weight of 178 daltons. Propofol is a weak organic acid with a pKa 
of 11, and at pH of 7.4, it is almost entirely unionised. It has a very high 
lipophilicity with an octanol/water partition coefficient of 3.7 [Skues and 
Prys-Roberts, 1989]. 
The commercial preparation Diprivan ( IeI Pharmaceuticals) consists of 
propofol 1 % W /v in an oil in water emulsion which containing 2.250/0 
glycerol for isotonicity, 10% soybean oil and 1.2% purified egg phosphatide. 
H 
o 
FIGURE 1.1. Structural formula of propofol 
CH (CH ~ 2 
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Propofol in Adult Anaesthesia 
Phannacokinetics profile 
Bolus dose studies 
The pharmacokinetic profile of propofol after a single i.v. dose, is 
usually described by a three-compartment model [Cockshott, 1985; 
Cockshott et aI, 1987a; Kay et aI, 1986; Kirkpatrick et aI, 1988]. The three 
exponential functions have been interpreted as (1) a fast distribution from 
blood to well perfused tissues, (2) a rapid metabolic clearance from blood, 
and (3) a slow return of propofol from a poorly perfused deep compartment 
into blood. Some studies proposed a two compartmental model [Adam et aI, 
1983; Schiittler, Stoeckel and Schwilden, 1985; Simons et aI, 1988]. The 
difference is probably related to the sampling method. 
The major differences in propofol kinetics from those of other i.v. 
agents are the very high clearance values (23.2 - 29.0 ml.kg- 1.min-1), 
exceeding the estimated hepatic blood flow (21 ml.kg.-1min-1) [Gepts and 
Camu, 1991], and a large apparent volume of distribution, two to three times 
as large as the volume of distribution at steady state, resulting in a very long 
terminal half-life (about 4-11 hours). This long terminal half-life indicates 
that propofol might accumulate when it is administered by either repeated 
bolus injection or prolonged infusion for maintenance of anaesthesia. 
Propofol in the concentration range of 0.1-20 Jlg.ml-1 is extensively bound to 
plasma protein (97-99%) mainly albumin, and this is similar in both young 
and elderly patients. This high protein binding does not seem to restrict the 
extensive tissue distribution. There is a larger interindividual variation in 
the kinetic parameters [Kanto and Gepts, 1989] which partly explains the 
variations in responses observed in clinical studies. 
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The initial volume of distribution is smaller and the total body 
clearance is lower in the elderly [Kirkpatrick et aI, 1988]. This is consistent 
with the reduction in the volume of highly perfused tissues, lower cardiac 
output [Leithe et aI, 1984], and the age-related ·decline in hepatic blood flow 
and metabolic capacity [Hull, 1991]~ 
Infusion pharmacokinetics 
Propofol is currently the hypnotic agent of choice for maintaining 
anaesthesia or sedation by intravenous infusion. During constant rate 
infusions, the concentrations at steady-state are proportional to the infusion 
rate, indicating linearity of the disposition kinetics within the dose range of 
3-9 mg.kg.-1h-1 [Gepts et aI, 1987; Cockshott et aI, 1990]. Pharmacokinetic 
studies have been performed in volunteers [Schuttler, Stoeckel and 
Schwilden, 1985], in anaesthesia [Cockshott et aI, 1987b; Cockshott et aI, 1990; 
Gepts et aI, 1987; Shafer A et aI, 1988; Gin et aI, 1991] and intensive care 
[Albanese et aI, 1990]. The infusion pharmacokinetic profile is fairly similar 
to those after a bolus injection [Cockshott et aI, 1987b]. Both two and three 
compartment open-models with central elimination have been used to 
describe the concentration-time relationship. The pharmacokinetic variables 
in infusion were, in general, within the same ranges as after bolus injection, 
and demonstrate a large interindividual variability, especially with regard to 
the volumes of distribution and the elimination half-life. The apparent 
volume of distribution (Vd) is two to three times the corresponding volume 
of distribution at steady state (V ss) resulting in very long terminal half-lives 
[Gepts and Camu 1991]. The rate constants for transfer from the third 
compartment (k31) were only a small fraction of the values for elimination 
constant (kIO), suggesting that a small proportion of the dose stays in the 
tissues and is slowly eliminated. 
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Metabolism and excretion of propofol 
Elimination of propofol is mainly through metabolism in the liver. 
However the existence of extrahepatic metabolism has been suggested 
during anhepatic phase of liver transplant [Veroli et aI, 1992]. A disposition 
study using sub anaesthetic dose of 14C-propofol in volunteers [Simons et aI, 
1988] showed that propofol was eliminated by metabolism to water soluble 
conjugates of the parent compound and its ring-hydroxylated derivatives. 
Excretion was predominantly renal (88%). The four major urinary 
metabolites identified were propofol glucuronide (53%), 1-(2,6- diisopropyl-
l,4-quinol) glucuronide (18%), 4-(2,6 diisopropyl-1,4-quinol) glucuronide 
(13%), and 4-(2,6 -diisopropyl-1,4 quinol) sulphate (9%). Less than 0.3% was 
found to be excreted as unchanged propofol. 
Pharmacodynamic profile 
Mechanism of action 
Electrophysiological and biochemical studies have shown that propofol, 
similar to other general anaesthetics, facilitates the interaction of y -
aminobutyric acid (GABA) with its specific receptor. This in turn causes 
potentiation of GABA-mediated chloride conductance, leading to neuronal 
hyperpolarisation and inhibition of subsequent depolarisation (Figure 1.2) 
[Collins, 1988, Concas et aI, 1991]. Recent work by Hara, Kai and Ikemoto 
[1993] has found that propofol directly activates the GABAA receptor-
chloride ionophore complex and evokes a chloride current with suppression 
of the neuronal excitability of the central nervous system. GABAA receptor-
chloride ionophore complex has been shown to be a hetero-oligomer 
consisting of five polypeptide subunits forming binding sites for GABA, 
barbiturates and benzodiazepines and chloride channel [Olsen and Tobin, 
Introduction 19 
1990]. The receptor site of propofol is believed to be different from that of 
benzodiazepines, barbiturates and GABA. Hara and colleagues [1993] have 
also found that high concentrations of propofol desensitise the GABAA 
receptor, which may result in suppression of the GABAA system. This may 
be the cause for the excitatory side-effects observed during propofol 
anaesthesia. 
FIGURE 1. 2. Schematic model of GABAA - receptor chloride inophore and 
proposed molecular mechanism of propofo!. Reproduced with permission 
from Salonen MA and Maze M. Molecular mechanism of action for hypnotic 
and sedative agents in Mechanisms of Drugs in Anaesthesia, eds Feldman S, 
Scurr CF, Paton W. Copyright 1993, the Edward Arnold Limited. 
Central nervous system effects 
The onset of anaesthesia following intravenous propofol occurs within 
one arm-brain circulation time. It has been explained by the short blood 
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brain equilibration half-life of 2.9 minutes in adult study [Schiittler, 
Schwilden, and Stoeckel, 1986]. The incidence of pain on injection is about 
30% when injected into small veins of the hand and lower when the 
antecubital fossa vein is used [Lees, McCulloch, and Mair, 1985; Stark et aI, 
1985]. The incidence of pain on injection was found to be 5.2% in the recent 
analysis from the phase IV study [McLeskey et aI, 1993]. Other effects 
include excitatory effects, such as spontaneous movements [Fahy, van 
Mourik, and Utting, 1985], hypertonous, or hiccup [Steegers and Foster, 
1988]. Seizures after propofol have been estimated as occurring one in 47,000 
administrations by the Committee on the Safety of Medicines in the United 
Kingdom [Bevan, 1993]. The central nervous system depression is dose-
related. It has a short duration of action. The fast redistribution and 
metabolism contribute to the rapid decline in plasma concentrations and 
awakening from anaesthesia [Kanto and Gepts, 1989]. Compared with other 
anaesthetic agent, recovery after propofol is pleasant and patients report 
being particularly" clear headed" [Steegers and Foster, 1988]. 
Dose requirements 
The effective bolus dose of propofol for induction of anaesthesia in 95% 
of healthy unpremedicated adult patients has been found to be 2.5 mg.kg-1 
in a multicentre trial [Cummings et aI, 1984]. Premedication with opioids or 
benzodiazepines decreased the induction dose of propofol, but had very 
little effects on the induction characteristics [Briggs et aI, 1985]. Propofol 
used for total intravenous anaesthesia has been studied in various 
anaesthetic protocols; as a bolus followed by incremental doses, zero-order 
infusion, manually controlled infusion and computer controlled infusion 
with or without opioids or nitrous oxide supplements. The dose 
requirements reported have varied widely depending on premedication and 
supplementary agents used during anaesthesia. 
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Cardiovascular effects 
Induction of anaesthesia with propofol causes a significant reduction in 
systemic arterial pressure (15-30%) because of decrease in cardiac output 
[Monk et aI, 1987; Lippmann et aI, 1988], decrease in systemic vascular 
resistance (SVR) [Claeys, Gepts, and Camu, 1988] or both [Grounds et aI, 
1985; Coates et aI, 1987; Gauss et aI, 1991]. It also resets the baroreflex to 
allow slower heart rates [Cullen et aI, 1987]. A recent study by Fairfield and 
colleagues [1991] has suggested that the conflict in the cardiovascular data 
was due to the biphasic effect of propofol on the cardiovascular system. An 
immediate marked reduction in SVR with an associated tachycardia, an 
increase in cardiac output, and a decrease in arterial pressure was followed 
by a phase of increased in SVR towards the baseline value, a decrease in 
heart rate and cardiac output, and a further decrease in arterial pressure. In 
an animal study, it was suggested that the cardiovascular depression 
observed in vivo was not related to intrinsic myocardial depression [Riou et 
aI, 1992]. When compared with other Lv. anaesthetic agents, propofol causes 
a greater reduction in arterial pressure than thiopentone [Grounds et aI, 1985; 
Fahy, van Mourik, and Utting, 1985; Lippmann et aI, 1988] and 
methohexitone [MacKenzie and Grant, 1985a; Gold, Abraham, and 
Herrington, 1987; Doze, Westphal and White, 1987; O'Toole et aI, 1987]. The 
haemodynamic response may · be advantageous in attenuating the 
hypertensive response during laryngoscopy which has been confirmed by 
various studies [Monk et aI, 1987; Coates et aI, 1987; Co~ey et aI, 1989; Fahmy 
et aI, 1990; Gin et aI, 1993]. 
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Respiratory effects 
Propofol causes respiratory depression. After induction with propofol, 
variable incidence of apnoea (up to 80% ) have been reported [Taylor et aI, 
1986; Gold, Abraham and Herrington, 1987; Goodman, Black, and Carter, 
1987]. Noninvasive respiratory measurements have demonstrated that 
propofol causes a significant reduction in tidal volume, minute volume, 
mean inspiratory flow and functional residual capacity [Taylor et aI, 1986; 
Goodman, Black and Carter, 1987; Grounds et aI, 1987]. The ventilatory 
depression after propofol is greater than after thiopentone [Taylor et aI, 1986]. 
The effect was enhanced by the opioid premedication. Goodman and 
colleagues [1987] also found that propofol blunts the ventilatory response to 
an increase in inspired carbon dioxide. A greater degree of relaxation of the 
upper airway was observed after propofol compared with thiopentone 
[McKeating, Bali, and Dundee, 1988] 
Other effects 
Propofol has no adverse effects on liver [Kawar et aI, 1982; Stark et aI, 
1985] and renal function [Stark et aI, 1985]. Life threatening anaphylactoid 
reactions following propofol administration have been reported to be 
hypersensitivity reaction to propofol [Laxenaire et aI, 1988; Laxenaire et aI, 
1992; McHale and Konieczko 1992]. The incidence of seizures after propofol 
has been estimated to be 1 in 47,0000 administrations according to the Safety 
of Medicines in the United Kingdom [Committee of Safety of Medicines, 
1987; Bevan, 1993]. A consistent feature observed with propofol is the low 
incidence of postoperative nausea and vomiting [Stark et aI, 1985; McCollum, 
Milligan, and Dundee, 1988]. 
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Propofol in Paediatric Anaesthesia 
Propofol, after establishing a significant place in adult anaesthesia, was 
first used in children in 1985 [Purcell-Jones and James, 1985]. Since then 
clinical trials have been carried out in Europe and, later, in North America 
[Purcell-Jones et aI, 1987; Morton et aI, 1988; Mirakhur, 1988; Puttick and 
Rosen, 1988; Valtonen et aI, 1988; Patel et aI, 1988; Valtonen et aI, 1989a; 
Hannallah et aI, 1991]. 
Phannacokinetic profile 
Propofol pharmacokinetic variables in children have been estimated by 
studying the blood concentration-time profiles after a single dose [Saint 
Maurice et aI, 1989; Valtonen et aI, 1989a; Jones, Chan and Andrew, 1990] and 
during continuous infusion [Marsh et aI, 1991, Kataria et aI, 1994]. The 
paediatric blood-concentration time-profile after a single dose is best 
described by a three-compartment model as in adults. There are some 
variations in the results, probably from the differences in the methodologies. 
Jones and colleagues [1990] suggested that the influence of ethnic origin on 
metabolism may have contributed to a shorter elimination half-life observed 
in their study. However, there is a general agreement among the studies, 
that the metabolism and clearance of propofol in children is higher than that 
in adults. These results imply that 'children are likely to require a larger dose 
,f 
for induction of anaesthesia and a higher infusion rate to maintain a similar 
blood concentration as adults. This has been confirmed by induction dose 
response studies of propofol [Patel et aI, 1988; Hannallah et aI, 1991; Westrin, 
1991] and infusion studies in children between three and 12 years old [Marsh 
et aI, 1991; Browne, Prys-Roberts, and Wolf, 1992]. 
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Pharmacodynamic profile 
Central nervous system effects 
A dose of 2.5 - 3.0 mg.kg-1 is required in unpremedicated children to 
ensure a smooth transition to an inhalational-maintenance technique 
[Hannallah et aI, 1991]. Premedication reduces the requirement to 2.0 
mg.kg-1 [Patel et aI, 1988]. The onset of anaesthesia is fast, The mean onset 
time of 31 (SD 8.31) s was comparable with that of thiopentone (29 (SD 3.44) 
s) [Purcell-Jones et aI, 1987]. 
Spontaneous involuntary movements after propofol appear to occur 
more frequently in children with the incidence reported ranging from 10 -
75% [Borgeat et aI, 1991, Morton et aI, 1992]. The movements have been 
shown to be dystonic and choreiform in nature. However, detailed study 
with EEG tracings during induction showed no EEG abnormalities 
suggesting them to be subcortical in origin [Borgeat et aI, 1991]. Neurological 
side effects including seizures following propofol (during early recovery 
period and late onset) have been reported in adults and children [Laycock 
GJA 1988; Wittenstein and Lyle, 1989; Paech and Storey, 1990; Saunders and 
Harris, 1990; Thomas and Boheimer, 1991; Trotter and Serpell, 1992; Bevan, 
1993; Finley et aI, 1993]. Most of these episodes were transient and resolved 
spontaneously, although occasionally some persisted for a longer time. 
Athetoid movements and opisthotonus are the unusual features that are seen 
after anaesthesia which are almost confined to propofol [Bevan, 1993]. The 
cause for these excitatory adverse effects is unclear. The association between 
propofol and epileptogenic activity is controversial, because it is known to 
reduce the length of seizures during electroconvulsive therapy [Dwyer et aI, 
1988], and has been used successfully in controlling status epilepticus 
[Wood, Browne, and Pugh, 1988; Yanny and Christmas, 1988]. There were 
Introduction 25 
suggestions that fentanyl and alfentanil may potentiate the effect of propofol 
[Laycock, 1988; Wittenstein and Lyle, 1989]. 
The incidence of pain on injection in adults is higher when small veins 
on the dorsum of the hand are used rather than in the antecubital fossa 
[McCulloch and Lees, 1985; Stark et aI, 1985; Scott, Saunders, and Norman, 
1988]. It is therefore, expected that the incidence in children would be higher 
than in adults. The incidence in various paediatric studies ranges from 24 -
85% [Morton et aI, 1992]. Lignocaine 1 mg mixed with propofol 3 mg has 
been shown to abolish the pain on injection in the veins of the dorsum of the 
hand in a study of 50 unpremedicated children [Morton, 1990]. The 
minimum effective dose of lignocaine required to prevent pain on injection 
has been reported to be 0.2 mg.kg-1 by the same group [Cameron et aI, 1992]. 
Venous sequelae are rare [Hannallah et aI, 1991; Morton et aI, 1992]. 
Recovery in children after propofol induction has found to be faster 
than after thiopentone [Mirakhur, 1988, Valtonen et aI, 1988; Valtonen et aI, 
1989a; Runcie et aI, 1993]. Similar findings have been found with anaesthesia 
using propofol for both induction and maintenance [Puttick and Rosen, 1988, 
Borgeat et aI, 1990; Larsson, Asgeirsson, and Magnusson, 1992], whereas no 
difference in the recovery time after total propofol anaesthesia has been 
found in comparison with halothane anaesthesia [Martin, Nicolson, and 
Basgas, 1993], propofol followed by halothane [Doyle, McFadzean, and 
Morton, 1993]. The other advantage is a lower incidence of nausea and 
vomiting after propofol than after thiopentone, halothane or isoflurane 
anaesthesia [Watcha et aI, 1991; Larsson, Asgeirsson, and Magnusson, 1992; 
Martin, Nicolson, and Basgas, 1993; Snellen, Vanacker, and van Aken, 1993; 
Weir et aI, 1993; ]. 
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Cardiovascular effects 
Induction of anaesthesia In children is associated with a 15-25% 
reduction in systemic arterial pressure as in adults [Mirakhur, 1988; Morton 
et aI, 1988; Purcell-Jones et aI, 1987; Valtonen et aI, 1988; Saarnivaara, Hiller 
and Oikkonen, 1993]. This is associated with an initial increase in heart rate 
which then settles to the baseline or less with halothane maintenance. It has 
been suggested that the initial rise in heart rate was due to pain on injection 
[Morton et aI, 1992]. A recent study on QT interval and heart rate during 
induction in children found that propofol causes prolongation of the QT 
interval and results in a higher incidence of bradycardia and junctional 
rhythm than with thiopentone or methohexitone [Saarnivaara, Hiller, and 
Oikkonen, 1993]. There was no data on the mechanism of the hypotension in 
children .. 
Respiratory effects 
The incidence of apnoea during induction of anaesthesia with propofol 
in children ranges from 11 to 48% and is the same as that following 
thiopentone, but more frequent than after inhalational induction with 
halothane [Morton et aI, 1992]. Apnoea is usually transient but can last for 
over one minute. Premedication appears to increase the duration and 
incidence of apnoea. Other adverse respiratory effects such as hiccough, 
coughing, and laryngospasm are similar to those after thiopentone induction. 
Clinical experience 
There is an increasing experience in using propofol as a single-bolus 
induction followed by either inhalational agents or propofol infusion for 
maintenance of anaesthesia in children over three years of age for various 
general surgical, ENT, ophthalmic and dental procedures. In a recent study 
of cardiac surgery for children, propofol, in doses sufficient to produce burst 
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suppression on the EEG during cardiopulmonary bypass was found to 
reduce whole body oxygen requirements and the glucose and cortisol 
responses without increasing blood lactate concentrations. There was no 
increase in inotropic requirements and recovery was satisfactory [Laycock et 
aI, 1991a; 1991b; 1992]. Propofol has been found to be superior to 
thiopentone in sedation for diagnostic procedures such as CT scanning 
[Valtonen et aI, 1989b], magnetic resonance imaging [Vangerven et aI, 1992; 
Bloomfield et aI, 1993], and radiation therapy [Deer and Rich, 1992]. Airway 
control was satisfactory and recovery was faster than with thiopentone 
[Valtonen et aI, 1989a]. The safety of propofol for sedation in intensive care 
unit is not yet established. A recent report on five children with respiratory 
tract infection in whom metabolic acidosis, lipaemia, and death from fatal 
myocardial failure, after the use of propofol, has caused much concern 
[Parke et aI, 1992]. The exact mechanism of these fatal incidents remains 
uncertain. 
Children are ideal patients for day surgery [Morris, 1992]. A large 
proportion of paediatric surgery is for minor procedures that can be 
performed as day cases. This reduces the period of separation from parents 
and a familiar environment. Furthermore they are invariably accompanied 
by adults who provide supervision and care during the postoperative period. 
In North America, up to 60% of paediatric surgical patients are managed on 
a day-care basis [Steward, 1986]. In the United Kingdom, there is an increase 
paediatric day care surgery. Propofol, with its rapid elimination, has been 
shown to be a suitable anaesthetic agent for day-case anaesthesia in adults 
and it should be a potential alternative to thiopentone in children. Propofol 
has been shown to have a great potential as an agent for induction and 
maintenance of sedation and anaesthesia in children in the western 
hemisphere and a thorough evaluation of this agent in the Asian paediatric 
population is now warranted. 
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RESEARCH PLAN 
Paediatric research into propofol has been mostly on children over 
three years old. The studies in this thesis have ,been designed to investigate 
children from six months to twelve years of age. Short surgical cases without 
premedication were used in most of the studies to simulate a day-case 
setting. 
As growth in children is a dynamic process, the dose of propofol 
required in children of different ages may vary. The dose required for 
induction was determined in three groups of children: those aged less than 
two years, those between two and five years, and those between six years 
and 12 years old, using ED50 and ED95 for loss of the eyelash reflex and the 
acceptance of a face mask for the estimation. These end points were similar 
to those used in other paediatric studies to enable comparisons to be made. 
The induction characteristics of propofol were studied in comparison with 
thiopentone. Propofol causes a significant decrease in arterial pressure 
during induction of anaesthesia both in adults and children. Two studies 
were performed on the haemodynamic responses of propofol. 
Haemodynamic changes in response to different doses were studied during 
the dose finding investigation. Although the mechanism has been 
extensively studied in adults, it has not been investigated in children. The 
mechanism of cardiovascular response following propofol induction was 
conducted using a non-invasive technique of pulse-Doppler and two-
dimensional echocardiography to measure the cardiac output and the 
derived cardiovascular parameters. The incidence of apnoea and pain on 
injection were also determined during the induction studies. 
The single bolus pharmacokinetic variables for propofol were 
determined in children between one and 12 years of age, by studying the 
blood concentration-time profiles after 2.5 mg.kg-1 of intravenous propofol. 
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This was to examine for any age-related difference in kinetics that might 
account for the difference in dose requirements in the children of different 
age groups. Plasma protein binding of propofol was compared with that of 
adults. 
The development of computer-controllable infusion pumps has made 
administration of total intravenous anaesthesia easier and more precise than 
using manual-infusion pumps. Propofol infusion for induction and 
maintenance of anaesthesia was evaluated in children using a computer 
infusion pump. This enabled the paediatric pharmacokinetic algorithm 
which was recommended in the literature to be evaluated in the local 
paediatric population. The anaesthesia and recovery characteristics of the 
propofol infusion technique was then compared with three relatively more 
conventional techniques using either thiopentone, propofol or halothane for 
induction followed by halothane for maintenance. 

























All studies were approved by the Clinical Research Ethics Committee 
of the Faculty of Medicine of the Chinese University of Hong Kong. 
Informed consent from both parents of all the patients were obtained before 
the study. 
Patient selection and Anaesthesia 
Only healthy children were studied. Those with a history of allergy or 
adverse reactions to previous anaesthesia and those who were distressed or 
not amenable to coaxing were excluded from the study. Children with a 
haemoglobin level less than 11.5 g.dl-1 were excluded from research 
involving blood sampling i.e. pharmacokinetic studies. 
Children were not premedicated except for those in the cardiovascular 
part of the study, who received oral diazepam 0.4 mg.kg-1 about one to two 
hours before anaesthesia to ensure that they were not distressed during the 
measurement of cardiovascular parameters before the induction of 
anaesthesia. All children had EMLA emulsion cream (lignocaine 25 mg.g-1 
and prilocaine 25 mg.g-1), [Astra Pharmaceuticals, Sweden] applied to the 
dorsum of both hands about an hour before anaesthesia and were then 
covered with an impervious dressing. 
One of the veins under the EMLA cream patch was selected for 
intravenous cannulation for both drug and fluid administration. Another 
intravenous cannula was inserted in the contralateral arm after the patient 
was asleep for obtaining blood samples if required. All patients were 
monitored in accordance with the minimum standards set by the 
Association of Anaesthetists of Great Britain and Ireland and the Australian 
and New Zealand College of Anaesthetists. The monitoring included pulse 
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oximetry (Datex Satlite, Datex Instrumentarium Corp, Helsinki, Finland), 
end-tidal capnography (HP 78356A, Hewlett-Packard, California, USA.), and 
pulse rate and noninvasive automatic arterial pressure monitor (Dinamap 
1846SX, Critikon Inc., Florida USA). Anaesthesia was induced by either 
propofol or thiopentone according to the protocol. Standard techniques 
were used for maintenance of anaesthesia. Specific methods of anaesthesia 
used are outlined in the method section of the individual studies when 
relevant. 
All comparative studies were randomised using the sealed envelope 
technique. A separate stack of sealed opaque envelopes was prepared for 
each stratum within which randomisation took place. Stratification were set 
in studies involving large sample of patients covering wide age range, as this 
was believed to be a confounder of the effects studied. The observers were 
blind to the anaesthetic agent given. For the noninvasive measurement of 
cardiac output by two-dimensional echocardiography, a single paediatric 
cardiologist was invited to perform the measurements. For the recovery 




Cardiac output was measured noninvasively by the technique of 
pulsed Doppler echocardiography. Cardiac output measurements by this 
method has been shown to be reliable and highly reproducible [Alverson et 
al , 1982; Rein et aI, 1986; Mellander et al ,1987]. Doppler derived cardiac 
output has good correlation with that by dye dilution technique (r = 0.93 -
0.98). The 95% confidence limits for the difference between the two 
techniques was -16% to +12% of the mean cardiac output [Tibballs, Osborne, 
and Hockmann, 1988a]. However, Doppler technique has several 
limitations. The accuracy in cardiac output determination is dependent on 
the measurements of aortic diameter and mean blood flow velocity. Most 
investigators used the aortic diameter to derive the cross - sectional area 
(CSA = 1t X r2). Accurate imaging of the area may be difficult at times. 
Cardiologists compensate this by ensuring that the ultrasound beam is in 
parallel alignment to the velocity vector (incidence angle less than 200) to 
obtain the most accurate blood flow velocity. The accuracy may also be 
affected by motion. Patients with neck deformity, abnormal aortic valve or 
arch, or surgical emphysema are difficult to study. Doppler 
echocardiography, because of its noninvasive nature and its ability to 
provide information on a beat-to beat basis, is useful in assessing the changes 
in stroke volume and cardiac output more accurately than in determining the 
absolute flow rate, owing to cancellation of systemic errors [Calafiore, and 
Stewart, 1990] 
Stroke volume was measured by an ultrasound scanning device 
(Aloka-280, Aloka Co.~Ltd., Tokyo, Japan) using a handheld Doppler probe 
of 5 MHz. An initial two-dimensional echocardiogram was scanned along 
the parasternal longitudinal axis to obtain the internal aortic diameter at the 
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aortic annulus. Three measurements were performed and the average was 
taken as the aortic diameter. Pulsed-wave Doppler signals from the 
ascending aorta were then identified and recorded by placing the transducer 
probe at the suprasternal notch. The transducer was positioned to align the 
transmitted sound beam as parallel as possible to the velocity vector of the 
blood flow. All the computations were performed by the built-in program of 
the ultrasound scanner. The Doppler recordings and ECG tracings were 
recorded on videotape for later analysis. 
A two-dimensional echocardiography was chosen because it is more 
accurate than M- mode echocardiography. M-mode calculates volume from 
a measurement in a single dimension, and therefore any error made during 
the measurement could be magnified in the subsequent calculations [Slavik, 
1988]. The diameter of the aortic annulus was measured because it does not 
change during systole and therefore calculation of cardiac output using 
measurement at this site agrees more closely with invasive techniques than 
using aortic root measurements [Rein et aI, 1986]. Pulsed Doppler has been 
suggested to be a better technique than continuous Doppler. Pulsed Doppler 
permits measurement of flow velocity by range-gating at the specified 
location (eg: the aortic orifice), whereas continuous wave Doppler measures 
velocity along the entire beam path and may include an area with a parabolic 
velocity profile which may give a misleading Inean spatial velocity [Tibballs, 
Osborne and Hockmann, 1988a]. 
The velocity of the blood flow was calculated by the Doppler 
equation:-
v = ~ f c / 2 fo 
Any deviation of the transducer from the parallel axis of more than 200 angle 
was corrected by the formula:-
V = ~ f c / 2 fo Cos e 
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where V = velocity of blood flow; fl. f = change in frequency; c = sound 
velocity in the blood; fo = transmitting frequency; e = angle of insonance or 
the angle between the beam of ultrasound and the direction of blood flow. 
Stroke volume (SV) was computed by multiplying the average time 
velocity integral by the aortic cross-sectional area using the formula:-
t=ET 
SV = CSA I, V fl.t 
t= 0 
where CSA = cross sectional area of aorta, V= velocity, t = sampling interval 
and ET = ejection time. 
The stroke volume was calculated by averaging the measurements 
obtained from three consecutive cardiac cycles. 
Cardiac output was calculated by the product of stroke volume and 
heart rate. Surface area was derived from a nomogram for infants and 
children [Documenta Geigy, 1970] to calculate the stroke volume index and 
cardiac index. Systemic v~scular resistance (SVR) was calculated using the 
following formula [Kaplan, 1987]. 
SVR (dynes. sec. cm-S ) = Mean arterial blood pressure X 80 
Cardiac output 
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Arterial pressure monitor 
Arterial pressure was recorded using an automatic blood pressure 
recorder (Dinamap 1846SX, Critikon Inc., Florida, USA). Dinamap apparatus 
has been assessed in children of various age groups [Friesen and Lichtor, 
1981; Park and Menard, 1987]. Using Dinamap, systolic pressure was 0.94 
(intraarterial reading) + 3.54 (r= 0.96) and diastolic pressure was 0.98 
(intraarterial reading) + 1.7 (r= 0.94) in neonates [Fries en and Lichtor, 1981]. 
In infants and children, 90% of patients had an error of 5 mm Hg or less for 
systolic pressure, and 72% of patients had an error of 5 mm Hg or less for 
diastolic and mean pressures. Correlation coefficients for systolic was 0.970; 
diastolic 0.903 and mean arterial pressure 0.917 [Park and Menard, 1987]. 
These studies conclude that oscillometric determination of arterial pressure 
with the Dinamap is reliable and accurate in infants and children. However, 
its functions may be affected by poor peripheral pulsation, severe 
dysrhythmia and motion artifacts. 
Pulse oximeter 
Arterial oxygen saturation was monitored by Datex Satlite (Datex 
Instrumentarium Corp. Helsinski, Finland). This apparatus was assessed by 
Clayton and colleagues [1991]. They have shown that 95% of readings were 
within 3% of the reference value (co-oximeter reading which was taken as 
standard). The assessment has ranked this apparatus to be high on the list of 
performance in terms of a combination of accuracy, precision, and the 
number of readings within 3% of the reference reading. Although pulse 
oximeter is a standard component of anaesthetic monitoring, errors in Sa02 
reading can occur from various influences such as motion, ambient light, 
presence of abnormal haemoglobin. Sa02 is also underestimated in low Sa02 
( <700/0). 
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ASSAY OF PROPOFOL 
The assay of propafol concentration in whole blood was measured by 
high performance liquid chromatography (HPLC) [Plummer, 1987; Chan and 
Gin, 1990] 
Propofol is significantly bound to the formed elements of blood and 
therefore, whole blood is the preferred sample for analysis [Plummer, 1987]. 
Blood samples were collected in lithium-heparin tubes and stored at 40 C 
until analysis. Stability tests showed that propofol in blood samples was 
stable for a period of three months. The average recovery of propofol from 
whole blood was 93% ( range 90-980/0) at 500 ng.ml-1. 
All chemicals used were of analytical grade unless specified 
otherwise. Cyclohexane, O.lM sodium dihydrogen phosphate, glacial acetic 
acid and thymol were supplied by British Drug House, Poole, United 
Kingdom, tetramethylammonium hydroxide by Sigma Chemical Company, 
St Louis, USA, and acetonitrile HPLC grade by Mallinckrodt Inc, Paris, 
Kentucky, USA. The mobile phase consisted of 66% (v Iv) acetonitrile in 
distilled water containing 1 % (v Iv) glacial acetic acid. The operating 
pressure was 5330 kPa and the solvent flow rate was 1.6 ml.min-1. Glacial 
acetic acid was used in preference to trifluoroacetic acid to prevent the 
possible corrosion of the pump by the latter. 
The HPLC consisted of the following components: the solvent 
delivery system (M510 pump, Waters, Milford, USA), injector (Rheodyne 
7125, Cotati, California, USA), C18 reversed phase column (Nova Pak in a 
Waters RCM compression module, Waters, Milford, USA) linked to a C18 
pre-column, fluorometric detector (HP 1046A Hewlett Packard Waldbronn, 
Germany) with excitation and emission wavelengths set at 276 nm and 310 
nm respectively and integrator (HP 3396 A, Hewlett Packard, Avondale 
Pennsylvania, USA). 
Methods 39 
The internal standard thymol (12 ng in 50 J.lI), O.lM sodium 
dihydrogen phosphate buffer pH 4.6 (1 ml) and 5 ml cyclohexane were 
added to the blood sample (O.5ml). After mixing for 15 minutes, the samples 
were centrifuged at 200 C for 15 minutes at 3000 rpm. The organic extract 
(cyclohexane layer) was transferred into a tapered glass tube and made 
alkaline by adding tetramethylammonium hydroxide (50 J.lI) and evaporated 
to dryness at 37°C under a gentle stream of nitrogen. The residue was 
redissolved in acetonitrile (80 J.lI). The concentrate (10-15 J.lI depending on 
the concentration) was analysed by HPLC with fluorometric detection. An 
additional standard (whole blood with known concentration of propofol) 
was used at the beginning and end of each run (approximately 14 samples). 
Each sample run took seven min with the internal standard appearing at 3.5 
min and propofol at 5.2 min. 
Calibration graphs were used for each batch and constructed from the 
mean of three trials at six concentrations of propofol. A known amount of 
"pure" propofol was weighed and serial dilutions were made to prepare 
stock solutions containing 100 J.lg.ml-1, 10 J.lg.ml-1, 1 J.lg.ml-1 of propofo!. 
Aliquots of these stock solutions were then added to propofol free blood to 
prepare the calibration standards which ranged from 50 to 3000 J.lg.ml-1 
(Figure 2.1). The calibration graphs relating the peak height ratios and 
concentration of propofol were linear over the range of 2 to 3000 ng.ml-1 
with intra-assay coefficient variation ranging from 9.96% at 50 ng.ml-1 to 
1.81 % at 3000 ng. ml-1 (mean 4.17%). The inter-assay coefficient of variation 
were 6.4% at 50 ng.ml -1 and 5.4% at 3000 ng.ml -1. The lower limit of 
quantification was approximately 2 ng.ml-1. The calibration data are listed 
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FIGURE 2. 1. Calibration graph for propofol, r = 0.999 
Methods 41 
PROTEIN BINDING METHODS 
Protein binding studies were carried out by equilibrium dialysis using 
an equilibrium dialyser (Spectrum, Texas, USA). 
Component of the system consisted of an equilibrium dialyzer with a 
Spectrapor 2 dialysis membranes with a molecular weight cut off of 12,000 to 
14,000. The dialysis buffer was S0rensen's phosphate buffer made isotonic 
with sodium chloride (pH 7.4). 
Blood samples were collected in lithium-heparin tubes. The blood 
samples were immediately centrifuged at 3000 rpm, 200 C for 10 minutes. 
The plasma was separated and stored at -70oC before analysis. A known 
concentration of propofol (usually 3000 ng.ml-1) was added to plasma and 
incubated for one hour at 37oC. Plasma samples (1 ml) containing propofol 
were dialysed against phosphate buffer (1 ml) without propofol in the 
dialyzer for 4 hours in a water bath at 370 C with a rotation speed of 15 rpm. 
After dialysis, samples from both the plasma and buffer chamber were then 
analysed for propofol content by HPLC. The percentage of protein binding 
was then calculated by the following formula. 
% bound drug = (Cp - Cbu)/Cp x 100 
where Cp = drug concentration in plasma and Cbu = drug concentration in 
buffer. 
Recovery of propofol was 100.6% when 500 ng.ml-1 was added (CV 
3.97%) and 104.3% (CV 5.03%) when 3000 ng.ml-1 was added. The inter-
assay coefficients of variation were 0.45% at 500 ng.ml-1 and 0.39% at 3000 
ng.ml-1. The intra-ass'ay coefficients of variation were 0.46% at 500 ng.ml-1 
and 0.5% at 3000 ng.ml-1. 
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PHARMACOKINETIC ANALYSIS 
Bolus dose study 
The blood concentration-time profiles after single intravenous bolus 
administration were analysed by a model-independent method based on 
statistical-moment theory and a compartmental method using the 
pharmacokinetic software packages MKMODEL (version 4.0, BIOSOFT, 
Cambridge, UK) [Cockshott and Haywood, 1992] and PKCALC [Shumaker, 
1986] running on an IBM compatible XT computer. The curve-stripping 
technique in the PKCALC program was used to estimate the number of 
points in the terminal log-linear portion of the concentration-time plots for 
the model independent method and to provide the initial estimates (Vc, Cl, 
k21, a, ~, y) for the compartmental analysis. 
The MKMODEL program was used to perform the following analysis. 
Moment Analysis. 
The area under the concentration-time curve (AUC) from zero and 
infinity and area under the concentration-time moment curve (AUMC) from 
zero time to infinity were calculated by the log-trapeziodal rule. For the 
purpose of this calculation, the concentration at time zero was taken as equal 
to the concentration at two minutes. 
Estimation of the infinite part of the curve was obtained using the 
formula: t'Cp/Lz 
where t'Cp is the drug concentration measured of the last blood sample and 
Lz is the overall elimination constant. 
Estimation of the infinite part of the AUMC was obtained using the 
formula: t'Cp/LzX (t'+ 1/Lz) 
where t' is the time that the last blood sample was collected. 
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Clearance {CI(NC)}, mean residence time {MRT}, apparent volume of 
distribution at steady state {Vss} were calculated from the following 
formulae: 
CI(NC) = Dose/ AUC 
MRT = AUMC/ AUC 
V ss(NC)= CI(NC) x MRT 
Compartmental analysis. 
Individual concentration-time data sets were fitted to the following 
tri-exponential equation: 
where Ct = concentration at time t; A, Band C are intercepts and a, B, and y 
are the slopes of the three exponential lines. 
A= 
Vc (a -~) (a-y) 
B= 
V c (~ - a) (~ - y) 
C= 
Vc (y-B) (y-a) 
where Xo = bolus dose of propofol 
Vc = central volume of distribution 
a, ~ and yare the hybrid rate constants 
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k21 = the micro rate constant describing transfer from the 
shallow peripheral compartment to the central 
compartment 
k31 = the micro rate constant describing transfer from the deep 
peripheral compartment to the central compartment 
calculated using the formula: 
k21 . clearance 
The volume of central compartment (Vc), clearance (Cl) and the 
hybrid constants giving the best fit were derived using the non-linear 
regression program in MKMODEL. The distribution and elimination half-
lives (t1/2a, t1/2~, t1/2y), the micro rate constants were calculated using the 
standard formulae [Gibaldi and Perrier, 1982]. 
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Infusion and pharmacokinetic modelling 
For the infusion study, an algorithm for pharmacokinetic model 
controlled infusion for paediatric patients which had already been 
prospectively tested [Marsh et aI, 1991] was used to evaluate its suitability 
and accuracy in the local paediatric population. After a pilot study of ten 
patients, the pharmacokinetic algorithm was modified using an iterative 
linear least-squares regression program. Propofol dosage required to 
maintain the desired blood concentration was delivered using an IBM 
compatible 386SX laptop computer connected via a RS232C serial interface to 
a computer controllable infusion pump (Ohmeda 9000, Medishield, UK) to 
control the infusion rate. A program was written in 'Cl (Turbo C, Borland, 
USA) to control the pump and provide graphs of blood concentration and 
infusion rates. 
The dose to maintain a constant blood level of propofol was based on 
patient weight. An initial bolus of propofol was delivered by zero order 
infusion at the infusion pump's top rate (1200ml. hr-1) to achieve the desired 
concentration rapidly according to the formula: 
A1 =C. V1. W (Equation 1) 
where A1 is the amount of drug in the central compartment, C is the desired 
concentration in the central compartment in ng.ml-1, V1 is the volume of 
central compartment in l.kg-1 and W is the patients body weight in 
kilograms. A modification of Euler's numerical integration technique [Shafer 
et aI, 1988, Maitre and Shafer, 1990] was used to calculate drug 
concentrations in the central compartment, so that infusion rate was 
constantly altered to maintain a constant theoretical blood level. Thus for a 
three compartment open model: 
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AI' = Al+ [k2l A2+ k3l A3 - (klO + k12 + k13) Al + R].~t 
where A2' = A2+ (k12 Al- k2l A2) .~t 
and therefore R = (Al'- AI) .~t-1- k2lA2 - k3lA3 + (klO+ k12+ k13) Al 
where AI, A2, A3 are the amount of drug in compartments 1,2 and 3; k12, 
k2l, k13, k31, k10 are the rate constants for transfer into and out of the 
peripheral compartments and elimination respectively (Figure 2.2); t = time 
and R = the infusion rate. AI' is the next value of Al. The initial value of Al 
was taken from equation I, with no allowance made for time taken for 
infusion of the bolus. The algorithm was iterated every ten seconds. The 
desired concentrations were adjusted according to standard clinical criteria, 
increases in concentration being made using bolus doses to make up the 
difference between current and desired amount of drug in the central 
compartment using equation 1 and decreases being made by switching off 
the pump and allowing the plasma concentration to decay until the new 
target concentration was reached. The algorithm for altering plasma 
concentrations was based on one described by White and Kenny [1990]. The 
model assumes that the drug effect is proportional to the concentration in the 
central compartment, that drug elimination is from the central compartment 







D = initial dose 
V1 =0.432 ml kg-1 
k10 = 0.0967 min-1 
k12 = 0.1413 min-1 
k13 = 0.0392 min-1 
k21 = 0.1092 min-1 





FIGURE 2.2. Three-compartment open model for infusion of propofol 
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STATISTICAL METHODS 
The individual statistical methods used in this thesis are described in 
the "methods" section in each chapter. Parametric and nonparametric 
methods were used where appropriate. Included in the list of parametric 
methods were the paired t-test, two sample t-test, Pearson correlation, 
analysis of variance (ANOV A), repeated measures ANOVA and probit 
modelling. Nonparametric methods used were Wilcoxon-Mann-Whitney 
test, Kruskal-Wallis test, the Spearman correlation test, the Chi-square test 
and Fisher's exact test for contingency tables. Data in the text are presented 
with mean (SD or Cl) or median (range) as relevant. All test assumptions 
were examined before a test is used. For example, normality of the data was 
assessed using half-normal plots and the Shapiro-Wilk statistic [Shapiro and 
Wilk, 1965]. If the data was found to have violated the test assumptions, 
suitable transformations of the data were made or alternative test procedures 
employed. In all statistical analysis, a type I error of 0.05 and a type II error 
of 0.2 was allowed, except where otherwise stated. To control the two types 
of errors to these levels, sample sizes were calculated based on the 
appropriate formulae. These sample sizes were then used as reference to 
gauge the size of the study. 
Probit analysis [Finney, 1971] was used in the quantal dose study. In 
this method, binary response variables based on cohorts of patients under 
different doses were measured and a dose response relationship was 
estimated on the log-dose scale. The relationship was linearized by a probit, 
logit or gompit transformation. Goodness of fit of the data to a particular 
transformation was performed by a Pearson's goodness-of-fit test. 
Differences between different age groups were inferred by testing the nullity 
of a group parameter. Parallelism of probit lines was tested using the 
parallelism chi-square. ED50 and ED95 were obtained using Fieller's Rule. 
Methods 49 
When parallelism between probit lines holds, relative potencies of the 
different groups can be obtained by taking the respective ratios of the EDSO· 
Repeated Measures ANOV A was used when appropriate to analyse 
responses that were measured repeatedly over time. This was performed by 
PROC GLM of the SAS package (SAS Institute Inc, Cary, NC, USA). In this 
method, analyses were performed on differences in the responses over time 
between groups, and time-group interaction, where significant interaction 
suggested that the differences were not constant over time. In the presence 
of non-constant group differences over time, differences between groups 
were further examined at different time points. A multivariate or pooled 
univariate test was used to test differences between groups. The data were 
subjected to a sphericity test for choosing the appropriate test. If p> 0.2 from 
this test, the pooled univariate results were used to provide a more sensitive 
test, but if p < 0.2, a multivariate test which gave more robust results was 
used. 
Accuracy of the pharmacokinetic model controlled infusion of 
propofol was performed using the methods and terminology previously 
described [Marsh et al , 1991] to allow direct comparison of results. Predicted 
error was defined as 
Predicted error = Cp (measured) - Cp (predicted) X 100% 
Cp (predicted) 
where Cp = plasma concentration of propofol. Bias was defined as the mean 
prediction error. Precision was defined as the mean of the sum of the 
absolute values of prediction error and it is a measure of the degree of scatter 
of the data about the line of perfect prediction. The least mean square error 
was estimated and this was used to update the individual sets of 
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pharmacokinetic parameters to improve the prediction accuracy of the 
pharmacokinetic model. 
All statistical analyses were performed on personal computers 
{Macintosh IT si, (Apple computer, Inc, California, USA), and IBM compatible 
PC computers) and the IBM 4381 computer at the Computer Centre, the 
Chinese University of Hong Kong. Statistical packages used were Statview IT 
(Abacus Concepts Inc, Berkeley, USA), SPSS-PC and SPSS-X (SPSS Ltd,. 
Chicago, Illinois, USA), SAS (SAS Institute Inc, Cary, NC,USA) and BMDP 
(BMDP Statistical Software Inc, Los Angeles, CA, USA). Patient raw data are 
presented in Appendix C (page 192). 
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INDUCTION DOSE REQUIREMENT 
Introduction 
It is well recognised that the body size and composition of children 
change throughout childhood [Friis-Hansen, 1961], and these changes by 
affecting pharmacokinetics may influence the dose requirement in 
clinical practice [Morselli, Franco-Morselli, and Bossi, 1980; Booker, 1989]. 
Studies have observed that children require a larger dose of propofol 
for induction of anaesthesia than adult patients [Purcell-Jones et aI, 1987; 
Morton et aI, 1988; Mirakhur, 1988, Valtonen et al 1988]. Two previous 
dose-response studies have shown that children require a larger dose of 
propofol for induction of anaesthesia than adults [Patel et aI, 1988; 
Hannallah et aI, 1991]. The data in these studies were not subdivided into 
different age groups. Growth and development is a continuous process 
throughout childhood, anq could affect the dose requirement at different 
ages during this period. This part of the study was designed to determine 
the induction dose of propofol using a quantal dose-response method in 
unpremedicated Chinese children of three different age groups. 
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Methods 
This part of the study was performed on 300 healthy Chinese 
children (ASA I and 11) aged between six months and 12 years who were 
scheduled for elective minor surgery. Children, who were grossly obese, 
with a known history of allergy or of any adverse reactions to anaesthesia 
were excluded from the study. For this study, obesity was defined as body 
weight in excess of the 97th percentile for the corresponding age taken 
from the standard chart for Chinese children [Lau et aI, 1987, Leung et aI, 
1988] 
Preoperative preparation included EMLA emulsion cream applied to 
the dorsum of both hands and it was covered with an impervious 
dressing about an hour before anaesthesia. The children were divided 
according to their age into three groups, group A (less than 2 years), group 
B (2 - 5 years), and group C (6 - 12 years). Patients in each group were 
allocated to receive one of eight doses of propofol from coded envelopes 
in a randomised double-blind manner. The eight doses of propofol were 
1.2, 1.4, 1.6, 1.8, 2.0, 2.2, 2.4, and 2.6 mg.kg-1. 
The selected dose of propofol was injected intravenously over 
approximately 20 seconds through a 24 SWG cannula. Lignocaine 0.05 ml 
of 1% was added to each millilitre of 1 % propofol emulsion immediately 
before administration. This was fhe same dosage used by Patel and 
colleagues [1988] and by Brooker and Redfern [Brooker, Hull, and Stafford, 
1985; Redfern, Stafford MA, Hull CJ. 1985; Brooker, Redfern 1986]. 
Twenty seconds after completion of the propofol injection, the adequacy 
of induction was assessed by evaluating the patient's responses to 
brushing of the eyelashes (LER), and to the gentle application of a 
facemask (AFM) delivering 0.5% halothane and 70% nitrous oxide in 
oxygen. After this assessment, anaesthesia was continued as required 
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either by increasing the concentration of halothane or giving an 
incremental dose of propofol. Systemic arterial pressure and pulse rate 
were monitored throughout the procedure using a noninvasive 
automatic blood pressure monitor. An oximeter was used to monitor 
oxygen saturation. Pain on injection, apnoea and other side effects were 
noted. In older children, verbal complaint of pain or withdrawal of the 
arm in which the drug was injected, were taken to indicate pain, whereas 
in children less than three years old, grimacing, crying or a withdrawal 
response were taken as an indication of pain. 
Effective dose response curves for loss of eyelash reflex (LER) and 
acceptance of facemask (AFM) for 500/0 (EDso) and 95% (ED9S) in the three 
age groups were calculated and plotted using probit analysis as described 
in the methods chapter (page 48). The fitting of the probit curves to the 
raw values was assessed by Pearson's goodness-of-fit test. The differences 
between the dose response curves were analysed using the chi-square 
parallelism test. The differences between the effective doses of the three 
groups were tested by the t-test with Bonferroni adjustment using the 
software package Statistical Package for Social Sciences version 3.1. The 
adjustment was to limit the total probability of error committed in 
performing these tests to below 0.05. Chi-square tests were used to test for 
any association between dosage and the incidence of side effects. 
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Results 
Of the three hundred children in the study, 48 were in group A (less 
than 2 years), 117 in Group B (2-5 years) and 135 in Group C (6-12 year). 
Patients' details and the proportion in each age and dose group who 
demonstrated absence of eyelash reflex and acceptance of the facemask are 
shown in Table 3.1. Individual demographic data are listed in Appendix 
C (page 194). There were more boys than girls in the sample. This reflects 
the predominance of male genital procedures in minor paediatric surgery 
in the Prince of Wales Hospital, Shatin. 
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TABLE 3.1. Details of patients in each dose group (mean (SD) and 
numbers who demonstrated loss of eyelash reflex (LER) and acceptance of 
facemask (AFM). (From Aun et aI, 1992). 
Group A 





Dose Number Age (yr) Body Wt (kg) Sex 
mg.kg-1 of patients Mean (SD) Mean(SD) M:F 
1.2 4 1.2 (0.3) 10.3 (1.5) 4:0 
1.4 3 1.0 (0.1) 10.4 (2.4) 2:1 
1.6 7 1.2 (0.3) 9.3 (1.3) 6:1 
1.8 6 1.4 (0.4) 10.5 (0.9) 5:1 
2.0 8 1.4 (0.2) , 10.4 ( 1.6) 7:1 
2.2 7 1.4 (0.2) 9.9 (0.8) 5:2 
2.4 7 1.2 (0.4) 9.9 (2.0) 6:1 
2.6 6 1.4 ( 0.4) 10.0 (0.9) 4:2 
1.2 11 4.5 (0.9) 15.3 (2.9) 10:1 
1.4 13 3.9 (0.9) 16.5 (2.7) 10:3 
1.6 18 4.1 (1.2) 16.2 (3.8) 13:5 
1.8 12 3.7 (1.1) 14.3 (2.7) 12:0 
2.0 19 3.8 (1.3) 15.6 (3.2) 17:2 
2.2 14 3.7 (1.3) 14.8 (2.3) 10:4 
2.4 17 3.8 (1.5) 15.7 (3.1) 12:5 
2.6 13 3.6 (1.2) 16.2 (2.7) 10:3 
1.2 15 8.5(1.9) 26.3 (7.5) 11:4 
1.4 13 8.1 (1.8) 25.5 (7.2) 11:2 
1.6 20 8.9 (1.8) 28.2 (8.5) 19:1 
1.8 17 8.9 (2.0) 27.4 (7.9) 15:2 
2.0 18 8.5 (1.9) 25.4 (7.1) 11:7 
2.2 17 8.7 (1.6) 27.6 (8.3) 14:3 
2.4 18 8.5 (1.8) 24.9 (7.5) 11:7 
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FIGURE 3.1. Dose-response curves for loss of eyelash reflex (LER) 
and acceptance of fac~mask (AFM) in group A ( • ), group B ( • ) 
and group C ( .). Probability is the probability of response. (From Aun et 
aI, 1992). 
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The dose response curves for the LER and AFM in the three groups 
are shown in Figure 3.1. P- values for Pearson goodness of fit test for LER 
and AFM were 0.327 and 0.355, respectively which suggest that the dose-
response curves fit the data well. The ED50 and ED95 for both the LER and 
AFM were greatest in group A, less in group B and smallest in group C 
(Table 3.2). 
T AB LE 3.2. Estimated dose of propofol (mg.kg- 1) that is required to 
induce loss of eyelash reflex and acceptance of facemask in 50% and 95% 
of children (mean with 95% confidence' intervals). (from Aun et aI, 1992). 
Group A 
« 2 years) 
Loss of eyelash reflex 
E050 
E095 
1.79 (1.61 - 1.97) 
2.63 (2.36 - 3.02) 
Acceptance of facemask 
E050 
E095 
1.88 (1.69 - 2.09) 
2.88 (2.55 - 3.36) 
GroupB 
(2-5 years) 
1.58 (1.46 - 1.69) 
2.32 (2.14 - 2.59) 
1.66 (1.53 - 1.77) 
2.53 (2.31 - 2.86) 
GroupC 
(6-12 years) 
1.46 (1.35 - 1.56) 
2.14 (1.98 - 2.38) 
1.44 (1.32 - 1.55) 
2.20 (2.02 - 2.46) 
For both endpoints, the differences in ED50 and ED95 between groups 
A and C were statistically significant, whereas those between groups A 
and B were not. However, between groups Band C, a significant 
difference was observed in AFM but not in LER suggesting that LER is a 
less sensitive indicator than AFM. The relatively small number of 
patients in group A may have contributed to the difference in either LER 
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or AFM between groups A and B not being significant as there were 
relatively fewer suitable patients in those less than 2 years old. The dose 
requirements to achieve AFM were larger than those for LER in all three 




-0 o 0.1 0.2 0.3 0.4 
Dose (Log 1 c) 
FIGURE 3.2. Dose response curves of LER ( • ) and AFM ( 0) 
for all patients as a group ( n=300 ). 
0.5 
The p values of chi squared parallelism analysis of the dose response 
curves for both LER and AFM were not significant throughout the dose 
range (0.346 and 0.161, respectively). This demonstrates that the three 
curves were "parallel" which implies that a constant ratio between them 
can be deduced. If group C (with the smallest ED dose) is taken as the 
reference, the relative ratios of dose-response for LER were 1.3 and 1.2 for 
group A and B, respectively; those for AFM were 1.2 and 1.1 for group A 
and B, respectively. 
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The incidences of apnoea greater than 20 seconds duration were 0 -
28.6% in group A, 0 - 42.1% in group Band 5.9 - 52.9% in group C (Figure 
3.3). They were dose-related (p< 0.001). The apnoeic episodes, however, 
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FIGURE 3.3. Incidence of apnoea ~ 20 s in the three groups of patients. 
(From Aun et aI, 1992). 
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The incidences of pain were 0 - 42.9% in group A, 9.1 - 33.3% in 
group B, and 7.7 - 35.3% in group C (Figure 3.4). They were not dose-
related (p = 0.47). Involuntary movements were observed in 43.8% In 
group A, 54.7% in group Band 47.4% in group C. 
60 -
50-





-.§ 11 Group A en 30 -
-c: Q) D Group 8 ;: co 
Cl.. 
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Dose (mg kg-1) 
FIGURE 3.4. Incidence of paIn on injection In the three groups of 
patients. (From Aun et aI, 1992). 
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In this study, the mean arterial pressures decreased in all three 
groups. At two minutes after propofol, the reduction was greatest in 
group A (28.7%), less in group B (23.5%) and least in group C (18.0%). The 
pulse rate was relatively stable in group C (+ 1.4%), but decreased in 
groups A (-15.5%) and B (-12.2%) (Table 3.3). 
TABLE 3.3. Mean (%) changes in mean arterial pressure (MAP) and pulse 
rate (PR) at 1 minute and two minutes after propofol administration. 
MAP (mmHg) PR (bpm) 
BL lmin 2min BL lmin 2min 
Group A 89.6 70.0 63.9 145.0 122.0 122.5 
« 2 yr) (-21. 9%) (-28.70/0 ) (-15.9%) (-15.5% ) 
GroupB 85.4 71.7 65.3 112.0 107.0 99.8 
(2-5 yr) (-16.0%) (-23.5%) ( -4.5%) ( -12.20/0) 
GroupC 83.2 73.9 68.2 89.9 98.3 91.2 
(6-12 yr) (-11.20/0) (-18.0% ) (+9.3%) (+1.4%) 
Discussion 
Grossly obese children were excluded from the study, because their 
differences in body composition from their average counterparts may 
have a different dose requirement. 
The dose requirements for accepting facemask (AFM) is larger than 
those for loss of the eyelash reflex (LER) in all three age groups suggesting 
that the acceptance of a facemask occurred at a deeper plane of anaesthesia 
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than did the loss of the eyelash reflex. This is similar to the findings in 
other anaesthetic quantal dose-response studies in children [Cote et aI, 
1981; Patel et aI, 1988]. In a multicentre propofol dose-finding study in 
adults [Cummings et aI, 1984], three indicators were used to assess the 
success of induction. They were 1) cessation of counting, 2) loss of eyelash 
reflex and 3) dropping of a water filled 20 ml syringe held by the nozzle 
between the tips of the thumb and index finger with the arm extended. 
Loss of eyelash reflex was found to be the least reliable sign. However, the 
other two methods need cooperation from patients and are impractical in 
children. The acceptance of the facemask was considered to be a 
satisfactory end point, as in clinical practice, this criterion is usually used 
as an indicator of smooth transition to maintenance of anaesthesia with 
inhalational agents [Cote et aI, 1981; Patel et aI, 1988]. 
The ED50 and ED95 doses for both LER and AFM were greatest in 
children less than two years old, less in those between two and five years, 
and least in children above six years old. Hannallah and colleagues [1991] 
did not find any age-related differences in dose requirements and 
therefore they analysed their data in one group. However, a similar trend 
of differences has been observed in other studies [Morton et aI, 1988; 
Westrin, 1991; Manschot et aI, 1992]. The children studied were of a 
slightly different age range, and the methods for estimating the effective 
dose were also different. Morton used a titration method comparing 
children between one and five with those between five and 10 years old; 
Westrin used an up and down method to compare infants one to six 
months old with children 10-16 years old; and Manschot and colleagues 
[1992] compared the proportions of patients that were successfully 
induced in three age groups of children, three to five years, six to nine 
years and 10-15 years old. All these studies confirmed that younger 
children require a larger dose of propofol than older children and adults. 
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This may be attributed to differences in pharmacokinetics and 
pharmacodynamics between different age groups of children. 
The data from the current study was combined according to the 
corresponding age groups as in the studies by Patel and colleagues [1988] 
and Hannallah and colleagues [1991] for comparison (Table 3.4 ). 
TABLE 3.4. Comparison of effective dose values of propofol In children. 
LER AFM 
ED50 ED95 ED50 ED95 
Patel (1988) 1.6 ( 1.2- 1.9) 2.8 (2.3- 3.5) 2.5 (2.1-3.0) 5.2 (4.1-8.1) 
(1-12 yr) 
A1.n1 1.54 (1.5-1.6) 2.28 (2.2-2.5) 1.59 (1.4-1.7) 2.44(2.2-2.9) , 
(1-12 yr) 










2.44 (2.15- 3.16) 
The ED doses in children two to 12 years old in this study were 
similar to those in Hannallah's study. A two sample t-test was performed 
which confirmed that there was no significant difference between the 
results of the two studies (p=O.6). However, the lack of age-related 
difference in requirements in their study may be due their small sample 
size studied. In the study by Patel, the ED doses in the unpremedicated 
children are larger th~n in the current study. This may be related to both 
their small number of patients, and the use of extrapolation to determine 
some values. 
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Allowing for these differences in methodologies, there is a general 
agreement that healthy children require a larger dose of propofol than 
adult patients. It is therefore recommended that, doses in the range of 2.5 
- 3.5 mg.kg-1 are required for induction of anaesthesia in healthy 
unpremedicated children. In pracrice, the dose should be given by 
titration. The lower dose range is more suitable for older children and 
the higher range in younger children. Children with premedication 
should need less [Patel et aI, 1988]. 
Apnoea occurs more frequently in older children (see Figure 3.3) 
suggesting that either this side effect is age-dependent or that propofol is 
·more sensitive in older children. This finding confirms that of two other 
studies [Valtonen et aI, 1988; Manschot et aI, 1992]. 
The incidence of pain on injection in this study ranged from 0-
42.9%. The wider range observed in group A suggested that it is difficult 
to assess pain in children around one to two years old. The range in 
group Band C are more consistent. The dose of lignocaine used was 0.15 
mg per 3 mg of propofol which is the same as the dose used by Morton 
and colleagues [1988] and Patel and colleagues [1988]. The incidence 
obtained in the current series is on average similar to their incidences. 
However, Morton [1990] subsequently showed that 1 mg of lignocaine per 
3 mg propofol abolished injection pain in the veins of the dorsum of the 
hand in unpremedicated children. The minimum effective dose of 
lignocaine required to prevent pain in children was suggested to be 0.2 
mg.kg-1 [Morton et aI, 1992]. 
The reduction in arterial pressure and pulse rate were more 
pronounced in the younger age groups. This finding therefore needs 
further evaluation. 
The incidence of involuntary movements after propofol has been 
very variable in the literature depending on how closely the investigators 
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looked for them [Borgeat et aI, 1993]. The high incidence of involuntary 
movements observed in this study was similar to those reported by 
others [Purcell-Jones et aI, 1985; Borgeat et aI, 1991]. They were short lived 
and did not disrupt the conduct of anaesthesia and surgery. The origin of 
this side effects remains unclear. It has been shown that the frequency of 
these movements can be reduced by a slightly larger dose of propofol 
[Borgeat et aI, 1991] or administration of nalbuphine [Borgeat et aI1993]. 
In summary, healthy .children required a larger dose of propofol 
than adult patients. The dose of propofol required for induction of 
anaesthesia in unpremedicated children is in the range of 2.5-3.5 mg.kg-1. 
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INFLUENCE OF PROPOFOL DOSE ON HAEMODYNAMIC 
CHANGES 
Introduction 
A significant reduction in arterial pressure usually follows the 
induction of anaesthesia with a bolus dose of propofol in both adults 
[Fahy, van Mourik, and Utting, 1985; Grounds et aI, 1985; McCollum and 
Dundee, 1986; Coley et aI, 1989] and in children [Purcell-Jones et aI, 1987; 
Mirakhur, 1988; Valtonen et aI, 1988; Morton et aI, 1988; Hannallah et aI, 
1991]. Children require a larger dose of propofol for induction of 
anaesthesia than adults. It is possible that this increased dose 
requirement may have a dose-related effect on haemodynamic changes. 
To test this hypothesis, the haemodynamic changes after different doses 
of propofol were examined. 
Methods 
Two hundred and sixteen children from the study in Chapter 3 
were selected for this study. A stratified random allocation was used to 
divide the children into six groups depending on the dose of propofol 
received. These were 1.6, 1.8, 2.0, 2.2, 2.4, or 2.6 mg.kg-1. Those who 
received less than 1.6 mg.kg-1 were not included in this study, as the 
doses were too small. Such data may not be clinically relevant. Children 
with a known history of allergy or adverse reaction to previous 
anaesthesia were excluded from the study. All children had EMLA 
cream applied to the dorsum of both hands approximately one hour 
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before the estimated time of anaesthesia. No other premedicant was 
used. On arrival in the anaesthetic room, a noninvasive automatic 
blood pressure monitor was applied to one arm and a 24-gauge cannula 
was inserted intravenously into the other hand, which also had an 
oximeter probe attached to monitor the oxygen saturation. The child was 
allowed to settle and a baseline arterial pressure reading was taken. 
Following this, the predetermined dose of propofol was given over a 
period of approximately 20 seconds. One percent lignocaine 0.05 ml was 
added to each millilitre of propofol immediately before administration. 
The 'Dinamap' was programmed to cycle every minute and the arterial 
pressure and pulse rate were recorded on the attached printer. After 
assessment of the response to gentle application of a face mask, the 
patient was allowed to breathe a mixture of nitrous oxide 70% and 
halothane 0.5% in oxygen spontaneously through a modified Ayre's T-
piece. The child was not disturbed during the study period of five 
minutes, to avoid producing haemodynamic changes. Pain on injection 
was assessed by the reaction of the child during administration of the 
drug. In older children, the spontaneous complaint of pain or a 
withdrawal response was taken as indication of pain. For children under 
three years of age, grimacing, a cry on induction, or a withdrawal 
response was used instead. The attitude (anxious or calm) of the patient 
before induction was also noted. 
Statistical Analysis 
The demographic data were compared using analysis of variance 
and chi-square test. Blood pressure and pulse rate changes were analysed 
by a multivariate analysis of variance for repeated measures. 
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Results 
Data from three patients were incomplete and therefore excluded 
from the analysis. The demographic details of the six dose groups are 
shown in Table 4.1. There were no statistically significant differences 
between age, weight, and sex of the children in any of the dose groups. 
TABLE 4.1. Mean and standard deviation (SD) of age (years) and weight 
(kg) of patients in the six dose groups. 
Propofol dose 
(mg. kg-I) . 
Number(n) 
Age (yr) mean 
(SD) 

















2.2 2.4 2.6 
35 41 32 
5.2 5.0 4.9 
(3.2) (3.3) (3.2) 
19.7 18.6 19.7 
(8.9) (7.8) (7.8) 
27/8 28/13 25/7 
The preoperative arterial pressures and pulse rates were similar in 
all the dose groups. The mean values of systolic, diastolic, and mean 
arterial pressures decreased significantly following induction in all six 
, -
groups (p < 0.001). The changes in arterial pressures and pulse rate of 
individual patients are listed in Appendix C (page 199). The changes in 
mean arterial pressures for individual groups over the five minutes 
following induction is shown in Figure 4.1. The mean reduction in 
mean arterial pressure was approximately 15% over the first minute and 
apprOXimately 30% at five minutes after propofol. However, there was 
no difference between the six dose groups at any given time {between-
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group effect), [p values were 0.3, 0.6, and 0.9 for systolic, mean, and 
diastolic arterial pressures respectively]. There was also no significant 
difference in the rates of reduction in arterial pressure between the dose 
groups (group-time interaction) [p values were 0.8, 0.8, and 1.0 for 
systolic, mean, and diastolic arterial pressures respectively]. 
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FIGURE 4.1. Changes in mean arterial pressure following propofol. 
Mean values for each dose group. There was no difference between the 
groups at any given time. The rate of reduction was not different (From 
Short and Aun, 1991) 
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Changes in pulse rate showed a similar trend to that of the arterial 
pressures (Figure 4.2). There was a significant reduction in mean pulse 
rate of 17% over the five minutes following induction, although there 
was no differences between dose groups [p = 0.5 for between-group effect, 
0.7 for group-time interaction]. 
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FIGURE 4.2. Changes in mean pulse rate following propofol. Mean 
values for each group. There was no difference between the groups at 
any given time. The rate of reduction was not different (From Short and 
Aun, 1991) 
Thirty four percent of children appeared anxious before induction. 
The incidence of pain on injection was 24.1% • There was no significant 
difference in the incidence of anxiety or pain between the dose groups. 
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Discussion 
In an adult study, a dose-related decrease in arterial pressure and 
an increase in pulse rate were observed [Major et aI, 1981]. However, in 
the current study, the reductions in arterial pressures and pulse rates 
following propofol induction in children were not dose-related. The 
dose range used by Major and colleagues is similar to this study. A recent 
study on the dose of propofol required in children between three and 15 
years old produced similar findings [Manschot et aI, 1992]. The reason for 
this difference in response between adults and children is not clear. The 
propofol used in the adult study [Major et aI, 1981] was the old 
formulation in Cremophor, whereas the new emulsion formulation was 
used by Manschot and colleagues and in the current study. However, the 
difference is unlikely to be due to the use of different formulations of 
propofol used, as Glen and Hunter [1984] have shown similar anaesthetic 
and haemodynamic effects with both formulations. 
The magnitude of reduction in arterial pressure after propofol was 
similar to that of adults [Grounds et aI, 1985]. The reduction in pulse rate 
was greater than that in adults suggesting that the baroreflex is impaired 
more in children. However, it was not dose-related within the dose 
range studied (1.6 to 2.6 mg.kg-1). In contrast, Major and colleagues 
[1981] observed a dose-related initial rise in pulse rate and attributed this 
to the pain associated with propofol administration (80% when a small 
vein on the dorsum of the hand was used). The reason for the lack of 
tachycardia in this study is not clear. The pain incidence (24%) was lower 
than that observed by Major and colleagues [1981]. 
The inclusion of inhalational agents (nitrous oxide and 
halothane) in the study may be criticised. Both agents are known to 
influence haemodynamics but inhalational agents were necessary to 
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allow the cardiovascular monitoring. However such a technique may 
reflect more accurately the haemodynamic changes which occur in 
clinical practice. 
In children, because of ethical and technical constraints, invasive 
monitoring was not used. Instead, ·Doppler echocardiography was used, 
the results of which are presented in Chapter 5. 
In summary, induction of anaesthesia with propofol in children 
produces a reduction in arterial pressure and pulse rate. These changes 
were not dose-related. 
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CHAPTER 5 
Comparison of Cardiovascular Effects of Propofol and 
Thiopentone 
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COMPARISON OF CARDIOVASCULAR EFFECTS OF 
PROPOFOL AND THIOPENTONE 
Introduction 
Induction of anaesthesia with propofol caused a significant 
reduction in arterial pressures which was greater than that after 
thiopentone both in adults [Grounds et aI, 1985; Fahy, van Mourik, and 
Utting, 1985; McCollum and Dundee, 1986; Lippman et aI, 1988; Coley et 
aI, 1989] and in children [Purcell-Jones et aI, 1987; Valtonen et aI, 1988; 
Morton et aI, 1988]. 
In adults, the mechanisms of hypotension have been studied 
extensively by the invasive dye and thermodilution method [Grounds et 
aI, 1985; Coates et aI, 1987; Monk et aI, 1987; Claeys, Gepts, and Camu, 1988; 
Lippmann et aI, 1988] and the Doppler echocardiographic method 
[Fairfield, Dritsas, and Beale, 1991; Gauss et aI, 1991]. In adult studies, the 
cardiovascular effects of propofol have been controversial. Decreases in 
cardiac output [Monk et aI, 1987; Lippmann et aI, 1988], decreases in 
systemic vascular resistance (SVR) [Claeys, Gepts, and Camu, 1988] or both 
[Grounds et aI, 1985; Coates et aI, 1987; Gauss et aI, 1991] have been 
reported. Fairfield, Dritsas, and Beale [1991] suggested that the conflict in 
the results was due to a biphasic effect of propofol on the cardiovascular 
system. 
In children, the haemodynamic data are limited to noninvasive 
measurements of arterial pressure and heart rate and these are inadequate 
to describe the cardiovascular effects of anaesthetic agents [Wolf, Neal, 
and Peterson, 1986]. This study compared the cardiovascular effects of 
propofol with that of thiopentone in Chinese children using the 
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technique of pulsed-Doppler echocardiography. The accuracy and 
application of this method in paediatric patients has been described in 
Chapter 2 (page 34). 
Methods 
This study was performed on 45 healthy Chinese children aged 
between eight months and 12 years (ASA I or 11) and scheduled for 
elective surgery. Children with a history of allergy, or of any adverse 
reactions to previous anaesthesia were excluded from the study. Those 
children in whom pre-induction haemodynamic variables or venous 
access could not be obtained were withdrawn from the study. All patients 
were premedicated with oral diazepam syrup 0.4 mg.kg-1 and EMLA 
cream was applied to the dorsum of both hands approximately two hours 
before anaesthesia. The children were grouped into two age groups, less 
than two years old and between two and 12 years old. Children in each age 
group were then allocated randomly in a double-blind manner to receive 
either propofol 2.5 mg.kg-1 or thiopentone 5 mg.kg-1 . 
On arrival in the anaesthetic room, a noninvasive automatic blood 
pressure monitor was applied to one arm, and a 24-gauge intravenous 
cannula was then inserted into the opposite hand, where an oximeter 
probe was also attached for continuous monitoring of arterial oxygen 
saturation. The child was allowed to settle and the baseline 
haemodynamic measurements were obtained. The child was noted to be 
either calm or agitated at this stage. After the baseline recordings, the 
appropriate intravenous agent was injected over a period of 20 seconds. 
One percent lignocaine 0.05 ml was added to each millilitre of propofol 
immediately before administration. As soon as the child was asleep, a 
face mask was applied and anaesthesia maintained with 70% nitrous 
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oxide and 0.5% halothane in oxygen using the Jackson-Rees modification 
of Ayres T piece. Haemodynamic variables were then monitored at one 
minute intervals for five minutes from the end of the intravenous 
injection. End-tidal carbon dioxide concentration was monitored using a 
mainstream capnometer (HP 78356A, Hewlett Packard, California, USA) 
attached to the face mask. Fresh gas flow was adjusted and ventilation 
assisted if necessary to maintain end tidal carbon dioxide concentration 
between 4.7 - 6.0 kPa. After five minutes, the study was concluded, and 
anaesthesia and surgery proceeded as normal. 
Arterial pressures and heart rate were recorded by a 'Dinamap'. 
Stroke volume was obtained by an ultrasound scanning device (Aloka-
280, Aloka Co., Ltd., Tokyo, Japan) using a handheld Doppler probe of 5-
MHz. The measurement of stroke volume (SV), calculation of cardiac 
output (CO), stroke volume index (SVI), cardiac index (Cl) and systemic 
vascular resistance (SVR) have been described in Chapter 2 (page 35). 
Statistical Analysis 
In order to study and compare the effects of two agents in two age 
groups of children, the patients were divided into four groups for 
statistical analysis. They were: 
Group I, infants less than two years old who received propofol; 
Group 11, infants less than two years old who received thiopentone; 
Group Ill, children between two and 12 years who received propofol and 
Group IV, children between two and 12 years who received thiopentone. 
Patients' data between the same age groups were compared using a 
two-tailed Student's t test. The number of agitated children and the 
incidence of side effects were analysed by chi-square test. The baseline 
haemodynamic variables were compared by one way analysis of variance. 
The haemodynamic measurements after induction were analysed using 
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repeated measures analysis of varIance for the differences from the 
baseline values. The factors included were time after induction, 
anaesthetic agents, and age interaction. In the absence of statistically 
significant age by anaesthetic agent interactions, data from the four groups 
were compared simultaneously in the results. 
Results 
Four cases were excluded from the analysis because of their 
inadequate Doppler recordings. Of the 41 patients studied, 18 were infants 
(9 in group I, 9 in group 11), and 23 were older children (12 in group III and 
11 in group IV). Patient data and the ratio of agitated to calm children in 
each group are listed in Table 5. 1. Individual data are listed in Appendix 
C (page 204). 
There were no statistically significant differences in the mean age, 
body weight and surface area between group I and 11 or between group ITI 
and IV. In groups III and IV, there were more girls. There were more 
anxious children (P = 0.01) in groups I and 11 when compared with groups 
III and IV (Table 5. 1). 
Induction 81 
TABLE 5.1. Patient demographic data (mean ( SD) ). 
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Baseline haemodynamic variables were not significantly different 
between groups I and II or between groups III and IV (Table 5.2). 
The mean heart rates were greater (P = 0.001) and systemic vascular 
resistance values greater (P = 0.003) in the infants (groups I and 11) than 
their respective values in the older children (groups III and IV). The 
differences in the arterial pressures, systemic vascular resistance and 
cardiac index among the four groups were not statistically significant. 
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TABLE 5.2. Measured and derived haemodynamic variables before 
induction {mean (SEM)}. SAP = systolic pressure, DAP= diastolic pressure, 
MAP= mean arterial pressure, HR= heart rate, SVl= stroke volume index, 
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After induction, systolic, mean, and diastolic arterial pressures 
decreased significantly (P<O.OOl) in all four groups (Figure 5.1). In the 
infants, the maximum reduction in mean arterial pressure was 31 % after 
propofol (group I) and 21 % after thiopentone (group 11). In the older 
children, the maximum reductions were 280/0 after propofol (group Ill) 
and 14% after thiopentone (group IV). For both age groups, the 
differences were significantly greater after propofol than after thiopentone 
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FIGURE 5.1. Changes in arterial pressures and heart rate during 
induction of anaesthesia. Group I and 11 - infants less than two years old, 
group III and IV - children behveen hvo and 12 years old. BL = baseline 
(before induction); Time = time after induction. S = systolic pressure, M = 
mean arterial pressure, D = diastolic pressure. - = prcpofol; --- = 
thiopentone. (From Aun et aI, 1993) 
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Heart rate decreased significantly in infants who received propofol 
(24%), the decrease was significantly more than for those who had 
thiopentone (11%) (P = 0.024). The mean heart rate was stable in the older 
children who received either propofol (group Ill) or thiopentone (group 
IV) (Figure 5.1). There was a significant difference (P<O.OOl) in the 
magnitude of heart rate changes for the two age groups. 
Cardiac index which is a reflection of the combined effects of heart 
rate and stroke volume index, decreased significantly (P=0.005) in all four 
groups (Figure 5.2). In the infants the maximum decrease in cardiac index 
was 15% after propofol and 3% after thiopentone. In the older children, 
the maximum reduction was similar (10%) after each agent. 
There was an increase in stroke volume index after induction up to 
a maximum of 12% in the infants both after propofol (group I) and after 
thiopentone (group 11). In the older children, stroke volume index 
decreased maximally by 13% after propofol (group Ill) and 15% after 
thiopentone (group IV). These changes were not statistically different 
(Figure 5.2). 
Systemic vascular resistance decreased significantly (P=O.OOl) after 
induction in all four groups (Figure 5.2). The maximum reduction was 
similar for the infants who received propofol (15%) and those who 
received thiopentone (16%). The decrease in systemic vascular resistance 
in older children who received propofol was almost three times as much 
(19%) as the reduction in children after thiopentone (7%). The differences 
between the four groups were not significant. 
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FIGURE 5. 2. Changes in mean cardiac index (l.min-1.m-2), mean stroke 
volume index (ml.beat.-lm~2) and mean systemic vascular resistance 
(dynes.sec.cm-S r during induction of anaesthesia. Group I and II - infants 
less than tvvo ye~rs old, group III and IV - children betvveen tvvo and 12 
year~ old. BL = baseline ( before induction); Time = time after induction. 
-- = propofo]; --- = thiopentone. (After A un et aI, 1993) 
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None of the children showed signs of wakening during the study 
period. There were no differences between the four groups in the 
incidence of side effects (Table 5.3 ). 





























Equipotent doses are required for comparison of cardiovascular 
responses between two agents. The dose of thiopentone 5 mg.kg-1 was 
chosen as being equipotent to propofol 2.5 mg.kg-1. This ratio was based 
on previous works on their relative potencies [Grounds, Moore, and 
Morgan, 1986; Leslie and Crankshaw, 1990]. 
In this study, intravenous induction of anaesthesia in children 
using propofol was associated with more cardiovascular depression than . 
with an equipotent dose of thiopentone. This is similar to the findings in 
adults [Grounds et aI, 1985; Lippmann et aI, 1988]. The degree of 
cardiovascular depression in infants was similar to that in older children. 
The mean arterial pressure reduction after propofol was 
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significantly greater than after thiopentone in both the infants and older 
children (P = 0.011). The magnitude of arterial pressure reduction after 
propofol was similar to that found in other paediatric studies [Morton et 
aI, 1988; Hannallah et aI, 1991] and to the earlier haemodynamic study in 
this thesis (page 68). 
In healthy adults, thiopentone produces a reduction in arterial 
pressure and cardiac output, with or without a compensatory increase in 
total systemic vascular resistance [Elder et aI, 1955; Etsten and Li, 1955; 
Flickinger et aI, 1961] and a decrease in baroreflex sensitivity, associated 
with tachycardia [Bristow et aI, 1969]. The cardiovascular depression 
caused by thiopentone is due to a combination of depression of the 
vasomotor centre [Skovsted, Price and Price, 1970] and direct myocardial 
depression [Conway and Ellis, 1969; Sonntag et aI, 1975]. Venodilatation, 
causing a sequestration of blood volume in the venous side of the 
circulation, and, a reduction in the left ventricular diastolic filling and 
stroke volume, have also been suggested [Eckstein, Hamilton and 
McCammond, 1961]. The effect on arterial resistance vessels is variable as 
demonstrated by the inconsistent changes in systemic vascular resistance 
with barbiturates. 
The children receiving thiopentone in this study had a significant 
reduction in arterial pressure and cardiac index. However systemic 
vascular resistance decreased rather than increased. T-he changes in heart 
rate were different between the two age groups. The mean heart rate 
increased in the older children but decreased in the infants (Figure 5. 1), 
suggesting that the compensatory mechanisms are less efficient in infants. 
A comparative study of thiopentone in infants and children, observed a 
greater degree of myocardial depression than that in the present study 
[Tibballs and Malbezin, 1988b]. This was probably related to the larger dose 
of thiopentone (7.5 to 8.5 mg.kg- 1 ) and concomitant use of 
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suxamethonium in that study. 
Studies of the mechanism of propofol induced hypotension in 
adults have produced conflicting results [Fairfield, Dritsas and Beale, 1991; 
Lippmann et aI, 1991]. Lippmann and coworkers [1988] observed a 
reduction in left ventricle stroke work index (35%) and cardiac index 
(18% ) with no significant decrease in systemic vascular resistance and 
pulmonary vascular resistance. Andreev et aI [1988] using seven patients 
with Jarvik -7 artificial heart to control the variation in preload and 
cardiac output, showed that the cardiovascular depression was due to a 
peripheral vasodilatation involving venous, pulmonary and arterial 
vessels. Gauss et aI [1991] using echocardiographic assessment and end-
systolic quotient as an indicator of inotropy found that propofol-induced 
hypotension as a result of simultaneous negative inotropy and reduction 
in afterload. Grounds et aI [1985] observed a significant decrease in total 
systemic vascular resistance (18%) with minimal changes in heart rate 
and cardiac output. Fairfield, Dritsas, and Beale [1991] suggested that 
propofol has a biphasic effect on the cardiovascular system. After 
injection, there was a marked reduction in SVR with a compensatory 
tachycardia and increased cardiac output and the arterial pressure 
decreased despite the compensatory effects. This was followed by an 
increased in SVR towards baseline, a decrease in heart rate and cardiac 
output with a further reduction in arterial pressure. 
The magnitude of hypotension after propofol in this study, was 
similar to that in adults [Grounds et aI, 1985]. It was associated with a 
significant reduction in both cardiac index (10 - 15%) and systemic 
vascular resistance (15 - 19% ). Heart rate in the older children did not 
change, but it decreased significantly in the infants. The decrease was 
statistically but not clinically significant (Figure 5. 1). No biphasic effect, 
as described by Fairfield and colleagues [1991] was observed in the 
Induction 89 
children who received propofol in this study. More infants were crying 
on arrival in the operating theatre than the older children and this may 
have caused an increase in sympathetic tone resulting in a higher heart 
rates and systemic vascular resistance. Anaesthesia attenuates 
sympathetic tone and this may have contributed to the greater reduction 
in heart rate in the infants. However heart rates were all within the 
physiological range (Figure 5.1). Baroreceptor reflexes have been found to 
be more attenuated in both young animals and humans anaesthetized 
with halothane [Wear, Robinson, and Gregory, 1982; Gregory, 1982] or 
nitrous oxide [Duncan, Gregory, and Wade; 1981] when compared with 
adults. The difference in the reduction of heart rate is probably a 
reflection of a more significant baroreceptor impairment in the infants 
than in the older children. The decrease in heart rate after propofol was 
greater than after thiopentone. This suggests that propofol causes more 
baroreflex depression than thiopentone, similar to previous studies in 
adult patients [Cullen et aI, 1987; Ebert et aI, 1992]. Propofol has been 
shown to c(fuse a prolongation of the QT interval and results in a higher 
incidence of bradycardia and junctional rhythm than thiopentone or 
methohexitone in children [Saarnivaara, Hiller and Oikkonen, 1993] 
Paediatric patients are thought to have a limited ability to increase 
myocardial contractility and heart rate is an important factor in 
determining the cardiac output [Robinson, 1983]. However the infants in 
this study showed an increase rather than a decrease in stroke volume 
index associated with the reduction in heart rate. This suggests that the 
myocardium is capable of increasing stroke volume in this age group. 
Ventricular diastolic filling time and stroke volume are inversely 
proportional to baroreceptor reflex-mediated changes in heart rate. The 
net effect of these haemodynamic responses produced a nonsignificant 
difference in the reduction of cardiac index in all four groups. Like 
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thiopentone, there was no compensatory rIse In systemic vascular 
resistance following propofol. 
Haemodynamic effects during anaesthesia are affected by 
perioperative factors including drugs administered concurrently. 
Diazepam premedication was necessary to reduce anxiety and allow 
baseline haemodynamic measurements. A dose of 0.4 mg.kg-1 was used 
because at lower doses, excitement may occur from a lack of inhibition 
[Kosarussavadi, 1991]. Its use as premedication is not associated with 
significant cardiovascular depression [Fell et aI, 1985]. Any incidental 
haemodynamic effects caused by the premedication should be considered 
as relevant to the use of these induction agents in the clinical setting. 
Halothane and nitrous oxide have been shown to impair 
baroreflexes by resetting the baroreceptors [Bristow et aI, 1969]. Nitrous 
oxide preserves the sympathetic reflex to the vascular smooth muscle in 
skeletal muscle [Ebert, 1990], and may counteract the negative 
cardiovascular effects of the other agents during induction. Concurrent 
use of thes~ two inhalational agents may be criticized, but it reflects the 
situation observed in common clinical practice. 
In conclusion, propofol, as an induction agent, produces more 
hypotension than thiopentone. However there was no significant 
difference in the reduction of cardiac index between the two agents, and 
the degree of haemodynamic changes was acceptable in healthy children 
with either agents. 
Based on the two haemodynamic studies, it is suggested that, 
although the degree of hypotension after propofol is not of clinical 
significance in most instances, one should avoid propofol or modify the 
induction technique in patients with compromised circulatory function. 
A slower rate- of administration of propofol or pretreatment with a 
vagolytic agent may be used. 
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CHAPTER 6 
Single Dose Pharmacokinetics 
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SINGLE DOSE PHARMACOKINETICS 
Introduction 
Studies have consistently · shown that children require a larger dose of 
propofo! for induction of anaesthesia than adults [Purcell-Jones et aI, 1987; 
Morton et aI, 1988; Mirakhur, 1988; Valtonen et aI, 1988; Patel et aI, 1988; 
Hannallah et al; 1991; Manschot et aI, 1992]. Similarly, in infusion studies, 
children were found to require a higher infusion dose than adults for 
maintenance of anaesthesia [Browne, Wolf, and Prys-Roberts, 1990; 
Browne, Prys-Roberts and Wolf 1990, 1992; Marsh et aI, 1991]. 
Age-related physiological changes in the distribution of body water, 
and cardiovascular, hepatic, and renal function may affect the distribution, 
metabolism, and excretion of drugs. Special anaesthetic problems occur 
mostly in children under three years old [Annotation, 1978; Hatch, 1984] 
and in terms of pharmacokinetics, they represent a separate sub-group 
[Hull, 1991]. It is, therefore, possible that the increased requirement of 
propofol in younger children when compared with older children 
["Induction dose requirement" study page 52; Morton et aI, 1988; Westrin, 
1991], may, in part, be due to differences in the disposition of propofol. To 
test this hypothesis, disposition after a single intravenous dose of propofol 
was studied in children between one to twelve years old. The protein 
binding of propofol in children was also compared with that of adults. 
Propofol kinetics in children so far have only been studied in children 
older than three years old in the English language literature [Saint-




The study was performed on 26 healthy children aged between one 
and 12 years old undergoing elective minor surgery. Those who were 
grossly obese; who had a haemoglobin level less than 11.5 g.dl-1, systemic 
disease, a history of allergy or an adverse reaction to previous anaesthetics 
were excluded from the study. 
No premedication was given except for the application of EMLA 
cream to the dorsum of both hands about an hour before anaesthesia. 
Anaesthesia was induced with propofol 2.5 mg.kg-1 administered over a 
20-s period and the tracheal was intubated after atracurium 0.5 mg.kg-1. 
Ten milligram of lignocaine 2% was added to every 200 mg of propofol 
just before administration. Anaesthesia was maintained with 70% nitrous 
oxide and 0.5% halothane in oxygen. The patients' lungs were ventilated 
mechanically to maintain an end-tidal C02 concentration between 4.6 and 
5.3 kPa. Analgesia was provided by an appropriate regional block using 
bupivacaine. Intravenous fluid 0.18% saline in 4.3% dextrose was given at 
the maintenance rate until the patient could take oral fluids 
postoperatively. At the end of anaesthesia, residual neuromuscular block 
was antagonised with neostigmine and atropine. 
Venous blood samples (1.5 ml) were taken before induction of 
anaesthesia and at 2, 4, 6, 10, 15, 30, 45, 60, 120, 240, 360, 480, 720 minutes 
following propofol administration. The baseline sample was obtained 
from the intravenous cannula used for administration of propofol. A 
second cannula was placed on the opposite arm after the patient was 
asleep. Exact time of sampling was noted for those samples which were 
taken outside the protocol time. 
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Protein Binding study 
Plasma protein binding of propofol was studied in a different 22 
healthy children between 1-12 years old and compared with 11 healthy 
adults between 20-40 years old. A nine millilitre venous blood sample was 
obtained before anaesthesia for protein binding study, albumin and Cl1 acid 
glycoprotein assays. The reason for studying separate patients was to limit 
the volume of blood obtained for sampling from each individual patient. 
Handling of all the blood samples and subsequent analysis were as 
described in Chapter 2 (page 38). The pharmacokinetic parameters were 
estimated by a two-stage approach, using both model independent and 
compartmental methods. In the compartmental analysis, individual 
concentration versus time plots were fitted to a tri-exponential equation as 
this function was found to fit best in previous pharmacokinetic studies 
[Saint-Maurice et aI, 1989; Valtonen et aI, 1989a; Jones, Chan, and Andrew, 
1990; Kataria et aI, 1994]. 
Statistical Analysis 
The pharmacokinetic values obtained were correlated with 
body weight, and age after being standardized for body weight using 
the program incorporated in the MKMODEL program. Kruskal-




Data from three patients were excluded from the analysis because the 
blood sampling was incomplete. The demographic data of the twenty-
three children selected for the analysis are provided in Table 6. 1. 
TABLE 6.1. Patients demographic data 
No. Name Age Sex Bodywt Surgery 
(yr) (kg) 
1 LWY 1.0 M 13.4 Orchidopexy 
2 YTH 1.2 M 10.9 Hemiotomy 
3 TYH 1.5 M 12.0 Orchidopexy 
4 LCF 1.6 M 13.2 Orchidopexy 
5 WKP 1.66 M 13.2 Hemiotomy 
6 TPW 2.0 M 12.0 Orchidopexy 
7 CCW 1.7 M 11.7 Ex. branchial sinus 
8 TCY 2.0 M 12.5 Hemiotomy 
9 CCH 2.2 M 12.5 Hemiotomy 
10 AYYF 2.25 M 12.2 Hemiotomy 
11 LCL 3.0 M 10.7 Orchidopexy 
12 YKN 4.5 M 17.5 Ex. chest wall sinus 
13 NSK 4.7 M 15.4 Circumcision 
14 CKS 4.8 M 18.5 Hemiotomy 
15 LHL 5.33 M 17.0 Circumcision 
16 LKS 5.5 M · 17.7 Hemiotomy 
17 YKW 6.5 M 17.3 Circumcision 
18 TYH 7.0 M 22.4 Circumcision 
19 LHI 8.0 M 25.8 Circumcision 
20 TFL 10.0 M 24.7 Orchidopexy 
21 WKH 10.0 M 35.0 Repair buried penis 
22 NQD 12.0 M 30.0 Circumcision 
23 YHM 12.0· M 31.5 Ligation testicular vein 
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The individual blood concentration versus time profile of all patients is 
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FIGURE 6.1. The individual blood concentration time profile for all 23 
children. Blood samples with non detectable propofol concentration were 
not plotted on the graph. Sixteen patients had detectable propofol 
concentration at 480 minute time and only six patients at 720 minute 
time. 
The individual blood concentrations are listed in Appendix C (page 
210). The blood propofol concentrations decreased with time in all 
patients, but secondary peaks or plateauing of the concentrations were 
observed in nine patients between 45 and 120 minutes after the 
administration of propofol. At eight hours after propofol, only 16 patients 
had detectable propofol concentrations and the number decreased to only 
six by 12 hours' time (Figure 6. 1). 
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The individual and mean (SD) pharmacokinetic variables obtained 
from the model independent and compartmental analysis are listed in 
Tables 6. 2 and 6. 3. The mean apparent volume of distribution at steady 
state (V ss) and clearance (Cl) derived from the two methods of 
pharmacokinetic analysis were very similar. During the estimation of the 
pharmacokinetic variables, the area under the extrapolated part of the 
concentration-time plot was 1.82% (range 0.19% to 7.230/0) of the total area 
under the curve. 
Correlation regression analysis of weight and the Vss(NC) and 
CI(NC), V c(C) and CI(C) revealed a good correlation. The r values were 
0.754, 0.817, 0.781 and 0.798, respectively. All the p values were < 0.001. 
However, there was no correlation between age and any of the 
pharmacokinetic variables after being standardized for weight [V ss(NC) (r 
= 0.216, P = 0.33), CI(NC) (r = 0.245, P = 0.25), MRT (r= 0.04, p = 0.852), V c(C) 
(r = 0.025, P = 0.92) and Cl (C) (r = 0.231, P = 0.288)]. The hybrid rate 
constants and derived micro rate constants from the compartmental 
analysis are listed in Table 6.4. 
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The data on protein binding are displayed in Table 6.5. The mean 
plasma albumin concentration in children one to three years old was 
significantly higher than those in the older children and adults (p < 0.05). 
However, there was no difference when the values from the two groups of 
children were compared. The total protein and ex. 1 acid glycoprotein 
concentrations were similar in the three age-groups. The mean propofol 
free fraction was lowest in the one to three years old children, highest in 
the adults and intermediate in the children between four and 12 years old. 
However, the differences did not reach statistically significant level and 
there was no correlation between the albumin concentrations and the free 
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Discussion 
The pharmacokinetic parameters from previous single dose studies 
in children [Saint-Maurice et aI, 1989; Valtonen et aI, 1989a; Jones, Chan, 
and Andrew, 1990] (Table 6.6) vary somewhat with each other. The 
reasons include differences in the methodologies, small population 
samples, the limited accuracy in single-dose kinetic studies and possibly 
the difference in ethnic origins of the patients [Morton et aI, 1992]. 
TABLE 6. 6. Pharmacokinetic data from other paediatric single bolus d"ose 
studies 
Saint - Maurice et al Valtonen et al Jones et al Ka taria et al 
(1989) 
Age range (yr) 4-7 
no. of patient 10 
mean (SEM) 
0.722 (0.11) 
Vss ( l.kg -1) 10.90 (1.20) 
Cl 30.6 (2.9) 
( ml.min. -1 kg-I) 
t1/2a (min) 4.15 (0.78) 
t1/2~ (min) 56.1 (6.30) 

















Mean (SEM) Mean (SEM) 
0.597 (0.10) 0.78 (0.07) 
5.01 (2.66) 
40.4 (3.6) 57.0 ( 2.0) 
3.05 (0.43) 3.8 (0.39) 
24.3 (5.13) 51.5 (6.9) 
209.22 (29.3) 
Saint-Maurice and colleagues [1989] observed a 70% increase in the 
central volume of distribution in children compared with young adults 
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with a similar clearance value. Valtonen and colleagues [1989a] 
highlighted a shorter t1/2~. Jones and co-workers [1990] in their study of 
Chinese children had similarly observed a shorter t1/2~ and t1/2y ( 50% 
and 33% of the adults' values respectively). However, in spite of the 
variations, some general features are observed in children. The mean 
central compartment volume is larger, and the clearance value is higher 
than in adults. 
In this study, although there was a significant correlation of the 
pharmacokinetic parameters with body weight, there was no correlation of 
age with any of the pharmacokinetic variables after being standardized for 
body weight. This is consistent with the findings by Kataria and associates 
in paediatric patients [1992; 1994]. This result suggests that the difference 
in the dose requirements between the different age groups of children 
(above one year) is unlikely to be due to the age-related differences in 
pharmacokinetics. However pharmacodynamic differences cannot be 
ruled out. The central nervous system may have a different sensitivity to 
anaesthetic agents at different ages. Examination of phenobarbitone 
concentrations in neonatal brain tissue at autopsy had shown that the 
brain/plasma concentration ratio increases with gestational age [Painter et 
aI, 1981]. Furthermore, Onishihi and colleagues [1984] reported lower 
brain/serum phenobarbitone ratios in children than in adults. These data 
suggest that a higher serum phenobarbitone concentration is required in 
the younger age groups for comparable efficacy [Gilman, 1990]. Marsh and 
colleagues [1991] using a computer controlled propofol infusion system, 
have observed that children needed a higher target-concentration than 
adults to achieve a satisfactory induction. Similarly, thiopentone 
pharmacokinetics in children were not significantly different from those 
in adults [Sorbo, Hudson, and Loomis, 1984], although children 5-15 years 
required more thiopentone than adult patients [Cote et aI, 1981]. 
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This study may be criticized for the use of venous blood samples, 
inadequate early sampling after induction, and a short duration of blood 
sampling in the postoperative period. Propofol has a significant uptake 
into tissues, leading to the initial venous concentration being 
substantially lower than the arterial blood concentration. Ideally, arterial 
blood sampling should be used for a pharmacokinetic study. However 
strong ethical considerations prevented frequent sampling and using 
arterial blood to gain the maximal pharmacokinetic information. 
The high incidence of secondary peaks in children may reduce the 
confidence in variables calculated by compartmental analysis because 
peaks affect the accuracy of curve fitting [Gin et aI, 1990]. These peaks 
have been attributed to patient movements causing redistribution of 
propofol [Kay et aI, 1986; Cockshott et aI, 1987a; Gepts and Camu, 1991]. In 
the current study, two methods (model independent and compartmental) 
of pharmacokinetic analysis were used for comparison. Population 
derived pharmacokinetics may be unreliable because of the large 
interpatient differences in children [Kearns and Reed, 1989; Gilman, 1990]. 
The mean volume of distribution at steady state (Vss) and clearance (Cl) 
values obtained by the two methods were almost identical (Table 6.2 and 
6.3) and overall, the methodology appears valid. Kataria and coleagues 
[1994] in their thorough evaluation of the three approaches in the 
determination of propofol pharmacokinetics in children, found that the 
two stage, naive pooled technique and the mixed effects population 
analysis, which included the patient covariates in the estimation, gave 
similar results. The weight adjusted model provided a significant better 
description of the pharmacokinetic data but not the age factor. 
The results of bolus kinetic studies are often very variable in children 
and therefore difficult to compare. Studies vary in their methodology and 
pharmacokinetic analysis. Technically, multiple blood samples are 
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difficult to obtain and venous blood samples are usually used for 
pharmacokinetic analysis which are less accurate than arterial samples; in 
addition, accurate timing of blood samples is difficult. Furthermore there 
is a significant interindividual variation among the paediatric population. 
Polyexponential pharmacokinetics are not easily interpreted by simple 
examination and comparison of pharmacokinetic variables [Shafer, 1993]. 
However, a comparison with two paediatric and two adult studies was 
attempted after estimation of the confidence intervals of various 
pharmacokinetic parameters. The values are listed in Table 6.7. The study 
by Jones and associates was chosen because their patients are of a similar 
ethnic origin as this study, and that of Kataria and associates was selected 
because of their large series of data. The adult studies by Kirkpatrick and 
colleagues [1988] and Gin and associates [1990] were chosen because their 
methodology is comparable to the current study. Their patients were 
mechanically ventilated, single dose propofol was given, venous samples 
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Considering the differences in methodology, the pharmacokinetic 
variables from this study are quite similar to the single bolus kinetic 
studies by Jones and associates [1990] and by Kataria and co-workers in 
1992, but different from those in the mixed population data (bolus and 
infusion method of administration) in the more recent paper by Kataria 
and co-workers in 1994, and the infusion modelling kinetic study in this 
thesis (Chapter 7, page 111). The central volume of distribution estimated 
from the current bolus study is larger and clearance is higher than the 
corresponding values in the infusion method. . Similar difference is 
observed in the pharmacokinetic parameters in the two reports by Kataria 
and colleagues [1992; 1994] (Table 6.7). These findings confirm that single 
dose kinetic parameters are poor predictors for infusion administration. 
Most of the bolus studies had inadequate early and late blood samples. An 
adult kinetic study has similar finding [Schiittler, Stoeckel and Scwilden, 
1985]. There was a significant correlation between the sampling period, 
volume of distribution and terminal half-life, and an inverse relationship 
between the sampling period and clearance [Campbell et aI, 1988]. 
According to them, a sampling period of 52 hours is still inadequate to 
define the terminal elimination phase. Therefore the clearance values are 
generally overestimated and the terminal half-lives and volume of 
distribution are underestimated in most studies. 
A larger central volume of distribution and higher clearance in 
children than the values from adult studies [Kirkpatrick et aI, 1988; Gin et 
aI, 1990] may partly explain why children require a larger induction dose 
of propofol than adults. The higher mean ratio of k31: kl0 obtained in 
the current study compared with that in the study by Kirkpatrick and 
colleagues (0.1489 vs 0.0247) suggests that propofol returns faster from the 
peripheral compartment back to the central compartment for 
elimination. An increase in the clearance of many intravenous drugs 
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during childhood have been observed [Morselli, Franco-Morselli and 
Bossi, 1980; Sorbo, Hudson, and Loomis, 1984, Roure et al, 1987; Olkkola, 
Maunuksela, and Korpela, 1989]. 
In summary, there is no age-related differences in the 
pharmacokinetics parameters in this study to explain the difference in 
dose requirements in different age groups of children. The clinical 
application is that theoretically, during an infusion study, one single 
algorithm should be applicable for children from age one to 12 years. In 
other words, it is not necessary to use different pharmacokinetic 
parameters for different age groups of children. However, the target 
concentration required may be different from that suggested by the 
differences in pharmacodynan1ic response. The decision on dosage of 
propofol in paediatrics should take both pharmacokinetics and 
pharmacodynamic titration into consideration. 
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CHAPTER 7 
Pharmacokinetic-Model-Controlled Infusion of Propofol 
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PHARMACOKINETIC MODEL CONTROLLED INFUSION 
OF PROFOFOL 
Introduction 
Drugs for intravenous induction of anaesthesia have often been 
tried as a sole anaesthetic. Early experiences were frequently disastrous as 
the pharmacokinetics and toxicity of these drugs were not truly 
understood [Savege, 1979]. The interest in total intravenous anaesthesia 
in adults as well as in children has been rekindled by the availability of 
drugs such as propofol and alfentanil which have suitable 
pharmacokinetic and pharmacodynamic profiles. 
Earlier infusion regimens for propofol have been a mixture of 
bolus and linear infusion techniques [Roberts et aI, 1988; Shafer et aI, 1988; 
Browne, Wolf, and Prys-Roberts, 1990; Browne, Prys-Roberts and Wolf, 
1992]. However, this method has limited accuracy and flexibility and 
there is also, a need to remember the formulae for the infusion schedules. 
Infusion of intravenous agents for maintenance of anaesthesia has 
been simplified by the availability of computer-controllable infusion 
pumps that can be programmed to maintain a constant theoretical plasma 
concentration using appropriate pharmacokinetic algorithms [White and 
Kenny, 1990]. However, successful use of these algorithms requires a 
knowledge of plasma concentration-effect relationships for the drug in 
use and of the accuracy of the algorithm. 
In this study, the use of an algorithm for administering propofol to 
paediatric patients [Marsh et aI, 1991] to maintain anaesthesia was tested 
prospectively in Chinese children between four and 10 years old. The 
quality of anaesthesia using a propofol infusion delivered by this system 
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will be examined in conjunction with the recovery characteristics in the 
Chapter 8 (page 131). 
Methods 
The infusion system, controlling algorithm and rate constants for a 
three-compartment open model used to control the infusion rates are 
described in the method chapter (page 45). 
Thirty healthy children (ASA I) aged between four and 10 were 
studied. They had been full term babies, had no contraindications to the 
drugs used in the trial, had a haemoglobin level of more than 11.5 g.dl-1 
and were undergoing minor surgical procedures associated with minimal 
blood loss. EMLA cream was applied to the dorsum of one hand, one 
hour preoperatively to assist with intravenous catheter placement. 
Anaesthesia was induced with intravenous propofol given by an infusion 
pump and maintained using the propofol infusion and nitrous oxide 70% 
in oxygen. All patients breathed spontaneously. A Rees modification of 
Ayre's Tpiece and laryngeal mask airway were used for children who 
weighed less than 20 kg. A Magill system was used instead for those who 
were over 20 kg. 
The study was conducted in two parts. In the first part, ten patients 
were studied to determine the · accuracy of the paediatric infusion 
algorithm by Marsh and colleagues [1991] in the local paediatric 
population. For the first patient, the initial target plasma concentration of 
propofol was set at 10 Jlg.ml-1. This initial plasma concentration was then 
adjusted up or down by 2 Jlg.ml-1 for each subsequent patient according to 
whether or not the previous patient moved in response to surgical 
incision, which was made between five and 10 minutes after anaesthetic 
induction. Post-operative analgesia was provided at the end of the 
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procedure using bupivacaine 0.25% (maximum 2.0 mg.kg-1) by either 
direct infiltration into the operation site by the surgeon or local nerve 
block performed by the anaesthetist. The target concentration of propofol 
was adjusted to maintain a satisfactory depth of anaesthesia according to 
standard clinical criteria, including no movement in response to surgical 
stimuli and maintaining arterial pressure and heart rate within 20% of 
baseline values. Arterial oxygen saturation, noninvasive arterial 
pressure, heart rate and end tidal carbon dioxide were monitored 
throughout the procedure. Time from switching off the infusion until 
eye opening in response to verbal command was recorded. 
After analysis of the results of the first part of the study, the 
accuracy of the pharmacokinetic algorithm was improved using linear 
least squares regression. Another 20 patients were then studied 
prospectively to test the accuracy of the revised pharmacokinetic model. 
These patients were also part of a subsequent comparative study of the 
anaesthesia and recovery characteristics of paediatric patients undergoing 
minor elective surgery, using four anaesthetic techniques (Chapter 8, page 
132). The anaesthetic technique was identical to that used in the first part 
of the study except that the initial plasma concentration was 8 Jlg.ml-1, 
rectal paracetamol 10-20 mg.kg-1 was administered and the local 
anaesthetic block was placed before commencing surgery. The initial 
blood concentration of 8 Jlg.ml-1 was equivalent to a bolus dose of 3.5 
mg.kg-1 propofol. 
A second intravenous catheter was placed in a large vein in the 
opposite limb to that used for the propofol infusion after the patient was 
asleep. It was used for taking venous blood samples for later analysis of 
blood propofol concentrations. Two millilitre blood samples were drawn 
at the time of surgical incision and then at 5 - 10 minute intervals 
throughout the procedure. Up to five samples were also taken in the 
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recovery room during the first two hours following termination of the 
infusion. A maximum of twelve blood samples were obtained from each 
patient. Handling of blood samples and subsequent analysis are described 
in Chapter 2 (page 38). 
Statistical analysis 
Blood concentrations of propofol were compared with the 
concentrations predicted by the pharmacokinetic algorithm to calculate 
prediction error, bias and precision of the algorithm (Chapter 2, page 49). 
This was calculated for each patient and the overall mean values 
estimated. For patients in the second part of the study, precision during 
the infusion phase was also calculated for each individual about that 
individual's bias during infusion phase to test the ability of the infusion 
model to maintain a constant plasma concentration. This procedure was 
not performed for patients in the first part of the study because of the 
small number of patients studied and the small number of blood samples 
obtained. An iterative linear least-squares regression program which 
minimized the total squared prediction error for each patient, was 
performed to find revised rate constants that would best fit the study 
population. The mean squared errors for each patient before and after 
least squares regression were compared using a paired t test. Linear 
correlation was used to examine" the relationship between time to eye 
opening on command and the duration of infusion. 
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Results 
Demographic data of the patients in the two phases of the study are 
listed in Table 7.1. 
TABLE 7. 1. Patient demographic data, mean (range). 
Part 1 (n=10) 
Part 2 (n=20) 
Age 
(yr) 
5.2 (4- 7) 





18 (15 - 22) 6/4 
23.7 (15 - 43) 19/1 
Duration of 
infusion ( min) 
38 (18 -108) 
30 (18 - 56) 
In the first part of the study a total of 67 blood samples were 
obtained from the 10 patients. The target concentrations of propofol for 
satisfactory anaesthesia ranged from 5 - 13 Jlg.ml-1. The mean total dose 
of propofol administered was 372 mg (range 263 - 563 mg) and the mean 
rate of infusion was 29.8 mg.kg.-1h.-1(range 13.5 - 46.6 mg.kg.-1h.-1). The 
precision of the model was 24.8% and bias -18.5%. After the iterative 
linear least-squares regression procedure, the revised pharmacokinetic 
variables had a theoretical precision of 23.1 % and bias of -0.30/0 (Table 7.2). 
Fit of the model was significantly -improved (p<O.OOl). Mean time to eye 
opening on command after cessation of infusion, was 35 minutes (range 
19 - 68 min). 
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TABLE 7.2. Initial and revised rate constants for propofol using a three 
compartment open model for patients in the first part of the study, and 
prospective evaluation of the revised rate constants. 















-18.5 (-41.2 to 10.4) 
24.8 (6.5 to 41.2) 









-0.3 (-28.9 to 28.6) 
23.1 (8.2 to 31.8) 
Prospective 







-0.1 (-30 to 42) 
21.5 (8.4 to 43.1) 
11.9 (3.2 to 30.1) 
During the second part of the study, a total of 177 blood samples 
were taken from the 20 patients. Mean duration of surgery was 32 min 
(16 - 65 min). The mean propofol infusion rate was 28.4 mg.kg.-1h.- 1 
(range 7.5 - 44.2 mg.kg.-1 h. -1 ). The mean target concentration for 
maintaining satisfactory anaesthesia during the infusion phase was 6.6 
Jlg.ml-1 (range 3 - 11 Jlg.ml-1) and the mean total dose of propofol given 
was 409 mg (range 222- 797 mg). 
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Precision of the revised model was 21.5% and bias -0.1% (Table 7.2). 
The correlation between measured and predicted propofol concentrations 
is displayed in Figure 7.1 (r = 0.86, P = 0.0001), and the relationship 
between the predicted blood concentration and predicted error is shown 
in Figure 7. 2. 
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FIGURE 7. 1. Correlation between predicted and measured blood propofol 
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FIGURE 7.2. Comparison between predicted blood concentrations of 
propofol and prediction error, n = 177. ( From Short et aI, 1994) 
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The individual prediction errors are displayed over time in Figure 
7.3. Individual data are listed in Appendix C (page 213) Precision in 
individual patients during the infusion phase was 11.9% (range 3.2 to 
30.1 %). This indicates that the model was better at maintaining a constant 
plas'ma concentration than predicting what that plasma concentration 
would be. Further iterative-linear least squares regression of the 
pharmacokinetic variables did not result in a further theoretical 
improvement in bias or precision of the model. 
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FIGURE 7. 3. Individual prediction errors over time. (n= 20). 
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In the second phase of the study, the mean time to eye opening on 
command after termination of the infusion and nitrous oxide was 40 min 
(17 - SO min) and did not correlate with the duration of infusion (r = -0.2, 
P = 0.2) . Predicted blood concentration at this time was 0.S6 Jlg.ml -1 
(range 0.40-1.45 Jlg.ml -1). Four patients had an increase in blood propofol 
concentration in the last blood sample, obtained between 52 and 103 
minutes after cessation of the infusion. The magnitude of the increase 
was between 7 - 21 % and occurred at blood concentrations between 0.S3 
and 2.50 Jlg.ml -1. 
Discussion 
Compared with the original study by Marsh and colleagues [1991], 
the precision of the pharmacokinetic model-controlled infusion 
evaluated was lower (24.So/0 vs 20.1% ) and there was a large bias (-IS.5% ) 
in the results. This means that the algorithm overpredicted the 
measured plasma concentrations by lS.S% indicating that the 
pharmacokinetic data by Marsh and colleagues were not applicable in the 
local Chinese paediatric population. This model had been developed 
using children of similar ages and undergoing similar procedures to the 
patients in this study. The revised pharmacokinetic parameters were 
found to fit the 20 patients well on prospective evaluation in the second 
phase of study suggesting a difference in the pharmacokinetic profiles of 
children in the two studies. The infusion system using the kinetics by 
Marsh and colleagues [1991] has been reported to be satisfactory in a recent 
propofol infusion by Doyle and colleagues in Glasgow [1993]. 
The reasons for the difference in pharmacokinetic variables are 
unclear. Possible differences between the studies included the difference 
in the ethnic origin of the patients, no sedative premedication in this 
study, and the local regional block being performed at the end of surgery 
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rather than at the beginning, in the first part of the study. The central 
volume of distribution in this study was 25% larger than that of Marsh 
and colleagues. However, caution must be exercised in interpreting the 
pharmacokinetic parameters in the model after it has been subjected to an 
iferative least-squares regression procedure, because the relative 
contribution of each of the variables to the overall model is influenced by 
its order in the regression procedure. The revised model is regarded best 
as a mathematical algorithm that best fits the blood concentration-time 
profile of the drug, rather than a true-compartmental pharmacokinetic 
model. 
The measured blood levels from the 20 patients in the second part 
of the study were correlated with the theoretical predicted propofol levels 
based on the infusion models of pharmacokinetic sets obtained from (1) 
the bolus kinetic study in Chapter 6 (page 92), (2) the study by Jones and 
colleagues [1990] and (3) that by Kataria and colleagues (naive pooled 
approach) [1994]. All the parameter sets underpredicted the measured 
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FIGURE 7.4. Correlation between measured and predicted blood 
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FIGURE 7.5. Correlation between measured and predicted blood 
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FIGURE 7.6. Correlation between measured and predicted blood 
concentrations using the mixed kinetics from Kataria's study [1994], r = 
0.9. 
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The theoretical bias and precision were also calculated from these 
studies and are tabled. The set from Kataria and colleagues has a smaller 
bias and precision than those from the two bolus studies (Table 7.3). This 
finding emphasizes the unreliability of using the pharmacokinetic data 
derived from single dose kinetic studies to predict infusion regimens. 
TABLE 7.3. Bias and precIsIon of the paediatric pharmacokinetic 
parameters applying on the measured blood concentrations of the 20 
patients in the second phase study. 
Current 
(infusion) (bolus) 
Vc (ml.kg -1) 432 
k10 (min-1) 0.0967 
k12 (min-1) 0.1413 
k13 (min-1) 0.0392 
k21 (min-1) 0.1092 
k31 (min-1) 0.0049 
Bias (%) 1.74 
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The large infusion rates required for satisfactory anaesthesia in the 
first part of the study, when no local anaesthetic block had been 
. performed were of concern. The mean infusion rate of 29.8 mg.kg-1.h-1 
was 50% higher than the ED95 of 20.9 mg.kg-1.h-1 found in adult patients 
who had been premedicated with lorazepam [Turtle et aI, 1987] and, it is 
two and half. times higher than the ED95 of 10.5 mg.kg-1.h-1 in children 
who had a supplement of alfentanil at a mean plasma concentration of 
135 ng.ml-1 [Browne, Prys-Roberts, and Wolf, 1992]. The intralipid load at 
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this infusion rate was 0.32 g.kg-1.h-1 which is close to the recommended 
maximum infusion rate for intralipid of 0.5 g.kg-1.h-1. When using 
propofol for infusion, one should consider the use of the 2% propofol 
solution rather than the usual 1 % solution. 
The concept of balanced anaesthesia In total intravenous 
anaesthesia uses a combination of drugs to achieve a desired anaesthetic 
effects with suppression of stress response without cardiovascular 
depression [Savege, 1979]. Propofol is the only drug currently available 
which fulfills the qualities of the hypnotic component in total 
intravenous anaesthesia. An opioid is usually required to suppress the 
reflex response to noxious stimuli. An alternative approach avoiding 
opioids would be to use local anaesthesia to block the noxious stimuli. 
This gives the benefit of providing postoperative analgesia without the 
risk of respiratory depression in the recovery phase. This is particularly 
useful in paediatric anaesthetic practice. It was surprising to observe that 
the infusion rates required in the first part of the study (29.8 mg.kg.-1h-1) 
were reduced only slightly by performing a local anaesthetic block before 
surgery (28.4 mg.kg.-1h-1). The same pharmacokinetic model controlled 
infusion was used in a further 18 patients making a total of 38 patients to 
complete the pharmacodynamic study. This aspect will be described in 
Chapter 8 (page 132). The mean infusion rate in the 38 patients was 27.3 
mg.kg.-1h-1 (range 7.6 - 44.5 mg.kg.-1h-1). It is not sure why there was not 
a greater reduction in the mean infusion rate required. One possible 
explanation is that the surgery was commenced before the block was 
effective. A large part of the propofol dose would have been 
administered already by this stage. The regional block may be inadequate 
to block the response ' to the surgical stimuli, although the majority of the 
children appeared to be pain free in the recovery period. 
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The initial recovery was slow after cessation of infusion. The 
reasons· for the slow recovery include the more than seven fold difference 
in the mean theoretical concentration required to maintain anaesthesia 
(6.6 J..lg .ml-1) and the mean predicted concentration at which eye opening 
to command (0.86 Jlg .ml-1) occurred in this series of patients. The decay 
in plasma concentration after cessation of the infusion was prolonged 
even after the brief surgical procedures in this study. This point is 
demonstrated in the modelling of the decay curve of blood propofol 





































Figure 7.7. Modelling of the decay in blood concentration of propofol 
after cessation of an infusion to maintain a constant blood concentration 
of 6.6 Jlg ml-1 for 30 minutes and 60 minutes, and of a bolus dose which 
may attain this concentration (2.85 mg.kg-1). The dashed lines correspond 
to the mean blood concentration of propofol required to maintain 
satisfactory anaesthesia and that at which eye opening to command 
occurred. (After Short et aI, 1994) 
A bolus dose which attains a blood concentration of 6.6 Jlg .ml-1 
(2.85 mg.kg-1) and infusions to maintain blood concentrations at 6.6 Jlg 
.ml-1 for 30 min and one hour are displayed. It took 48 minutes in the 
case of 30 minute infusion and 59 minutes in the case of 60 minute 
infusion to reach 0.86 Jlg .ml-1 blood propofol concentration. A blood 
concentration of 6.6 Jlg.ml-1 was chosen because it was the mean blood 
concentration required during the infusion phase of the study. The mean 
predicted concentration of 0.86 Jlg .ml-1 at which eye opening occurred 
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was slightly lower than the concentration of 1.4 Jlg .ml-1 in a similar 
study [Doyle, McFadzean, and Morton, 1993]. However, both these figures 
were predicted values. In an earlier paper [Vandermeersch et aI, 1989], 
using a continuous infusion of propofol at a rate of 12 mg.kg.-1h.-1 in 
children of similar age, the mean concentration of propofol measured 
was 2.32 Jlg .ml-1 at the time of awakening. These patients were heavily 
premedicated with hyoscine and morphine, and fentanyl had been given 
intraoperatively. The patients took 39.6 (SD 12.6) minutes to wake up. 
Secondary peaks of propofol concentration were observed in four 
patients during the early recovery period. The incidence might have been 
higher if sampling had been carried out in the late recovery period. 
However sampling was performed only during the early recovery period 
because of the concern over the number of blood samples taken and 
because the objective of this study was to examine the accuracy of the 
algorithm during the infusion and the early recovery phase. The blood 
concentrations of propofol obtained during these peaks ranged between 
0.83 and 2.5 Jlg .ml-1, which exceeded the predicted concentration for eye 
opening on command. This indicates that there is a need for prolonged 
observation of these patients as there is a possibility that clinically 
significant resedation could occur. Secondary peaks after propofol bolus 
doses have been previously observed in children as well as in adults 
Uones, Chan, and Andrew, 1990; Gin et aI, 1990]. 
In summary, maintenance of anaesthesia using propofol by means 
of a pharmacokinetic-controlled infusion system is feasible in children 
provided the algorithm used is accurate for the population concerned. 
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Comparison of Anaesthesia and Recovery of Four Anaesthetic 
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COMPARISON OF ANAESTHESIA AND RECOVERY OF 
FOUR ANAESTHETIC TECHNIQUES 
Introduction 
There has been much interest in the recovery profile of propofol 
anaesthesia in children. Many studies have compared propofol either as an 
induction agent or as a total anaesthetic with various combination of 
thiopentone, halothane or isoflurane. [Mirakhur, 1988; Puttick and Rosen, 
1988; Valtonen et aI, 1988; Borgeat et aI, 1990; Larsson, Asgeirsson, and 
Magnusson, 1992; Martin, Nicolson, and Bargas, 1993; Runcie et aI, 1993; 
Weir et aI, 1993]. Most of these studies compare two methods at a time. 
One of the attributes of an intravenous anaesthetic agent as a 
component in total intravenous anaesthesia is that the recovery after the end 
of surgery should compare well with other conventional techniques [Booker, 
1989]. 
In this study, the anaesthetic and recovery characteristics of propofol 
infusion for induction and maintenance of anaesthesia were compared 
simultaneously with three established anaesthetic techniques, propofol, 
thiopentone or halothane for induction followed by halothane maintenance 
in children undergoing minor surgical procedures. 
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Methods 
This study was performed on 163 healthy Chinese children aged 
between three and 12 years scheduled for body surface surgery estimated to 
take less than one hour, and where a regional anaesthetic block could be 
performed for analgesia. Children who were uncooperative, unable to 
perform a simple child's puzzle, had a history of halothane anaesthesia 
within the previous three months, allergy to any of the study medications, or 
a previous adverse reaction to anaesthesia were excluded. Children in the 
study were randomly assigned to one of four groups: 
1) pp group - propofol by infusion for induction of anaesthesia, maintenance 
of anaesthesia with propofol infusion and 70% nitrous oxide in oxygen. 
2) PH group - propofol for induction, maintenance of anaesthesia with 
halothane and 70% nitrous oxide in oxygen. 
3) TH group - thiopentone for induction, maintenance of anaesthesia with 
halothane and 70% nitrous oxide in oxygen. 
4) HH group - halothane for induction, maintenance with halothane and 70% 
nitrous oxide in oxygen. 
No sedative premedication was given. EMLA cream was applied over the 
back of both hands approximately one hour before the time of anaesthesia to 
assist with the intravenous insertion of the cannula. 
In group PH and group TH, anaesthesia was induced with bolus 
doses of propofol (2.5 mg.kg-1) and thiopentone (4.0 mg.kg-1) respectively. 
Increments were given if necessary up to 1 mg.kg- 1. Anaesthesia was 
maintained with halothane 1-2% and 70% nitrous oxide in oxygen. In group 
HH, anaesthesia was induced and maintained with halothane 1-3% and 70% 
nitrous oxide in oxygen. In group PP, anaesthesia was induced and 
maintained with propofol by continuous intravenous infusion using the 
pharmacokinetic model controlled infusion pump. The details are described 
in the method chapter (page 45) and Chapter 7 (page 111). The target 
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concentration of propofol in the blood was initially set at 8 Jlg.ml-1 at 
induction and subsequently the concentration was adjusted according to 
standard clinical criteria to maintain an adequate level of anaesthesia. In 
group PP, the induction dose of propofol was calculated from the theoretical 
target blood concentration (8 J,lg.ml-1) and the revised central volume of 
distribution (432 ml.kg-1) obtained from the infusion study (Chapter 7, page 
111). The mean infusion rate was derived by dividing the total propofol 
maintenance dose by the duration of anaesthesia. The 20 patients in the 
second part study of the pharmacokinetic model controlled infusion of 
propofol (page 111) are included in the assessment in this study. 
Lignocaine 2% in a dose of 0.2 mg.kg-1 intravenously was given just 
before the administration of propofol in the PP and PH groups to reduce 
pain on injection. A Rees modification of Ayres T-piece and laryngeal mask 
airway was used for children who weighed less than 20 kg. A Magill system 
was used in those above this weight. The quality of the anaesthetic induction 
was graded as good (induction uneventful), adequate (presence of minor 
side effects which did not interfere with induction), or poor (presence of 
severe side effects which caused a difficult induction). 
The depth of anaesthesia in all patients was adjusted according to 
standard clinical criteria to prevent movement in response to surgical stimuli 
and to maintain arterial pressure and heart rate within 20% of baseline. 
Analgesia was provided by an appropriate regional nerve block and rectal 
paracetamol 10-20 mg.kg-1 given immediately after induction of anaesthesia. 
Arterial oxygen saturation, noninvasive arterial pressure, heart rate and 
capnometry were monitored throughout the procedure. All anaesthetic 
agents were discontinued at the same time at closure of the surgical incision. 
The laryngeal mask was removed at this time. 
Recovery was assessed by the recovery room nurses who were 
unaware of the anaesthetic technique used. The followings were recorded: 
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(1) time from the end of anaesthesia (discontinuation of anaesthetic agents) 
to achieving a full Steward score [Steward, 1975] (0, I, or 2 points were given 
to each of the three categories; conscious level, airway control, and 
movement. The maximum possible score is 6); 
(2) time from the end of anaesthesia to opening eyes and other simple 
activities on command; and 
(3) time from end of anaesthesia to orientation (able to tell name and age 
correctly). Psychomotor recovery was assessed by a simple child's jigsaw 
puzzle. The puzzle consisted of six different shapes and colours which 
needed to be placed in the appropriate places. All children were trained 
before the anaesthetic, by a research nurse who was not involved in the 
management of anaesthesia. The shortest time of three attempts to complete 
the task was recorded as the preoperative baseline time. This test was 
repeated at 30 minutes, one hour and two hours after anaesthesia. All side 
effects and adverse reactions during the study period were recorded. Rescue 
analgesia consisted of a parenteral opioid as prescribed by the anaesthetist 
concerned. 
Statistical analysis 
The demographic data were compared using analysis of variance 
(ANOVA) and preoperative psychomotor test data were compared with the 
chi-square test. The postoperative psychomotor test data were analysed 
using a k - sample Van der Waerden test. In this test, the times taken to 
complete the puzzle were ranked according to their values. Highest possible 
ranks were given to those cases who could not perform the test because of 
sedation. The ranks were then transformed into normal scores for the 
analysis. Significant results from the ANOV A and nonparametric k-sample 
test were further compared using Dunnett's t test or 2-sample Van der 
Waerden test with adjustments to the p-values where appropriate. The 
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differences between the preoperative and the postoperative psychomotor 
data were compared by the Wilcoxon sign rank test. 
Results 
Data from five cases were excluded from the analysis because these 
children required opioid administration to relieve their postoperative pain 
before the end of the study period. Patient data were similar in the four 
groups (Table 8.1). Individual demographic data are listed in Appendix C 
(page 216). Anaesthesia details and side effects are listed in Table 8.2. 
























Duration of anaesthesia was similar at about half an hour in the four 
groups. In group PP, the mean induction dose was calculated as 3.5 mg.kg-1 
and the mean infusion rate of propofol was 27.3 (SD 8.1) mg.kg.-1 h-1 (range 
7.6 to 44.5 mg.kg.-1 h-1). In group PH, the mean induction dose was 2.9 (SD 
0.8) mg.kg-1. The mean dose of thiopentone in group TH was 4.7 (SD 0.6) 
mg.kg-1. There were no statistical differences in the grading of quality of 
anaesthetic induction between the groups (p = 0.114). During induction, 
pain on injection was only observed in groups PP (18.4%) and PH (14.3%). 
Apnoea was significantly more frequent in the PP group (p=O.OOl). Eighteen 
patients (47.4%) in group PP, nine patients (21.4%) in group PH, seven 
patients (17.9%) in group TH and only one patient (2.5%) in group HH were 
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apnoeic for longer than 20 s after induction. The lungs of one child in group 
pp had to be ventilated by hand throughout the procedure because of the 
apnoea, yet the child moved in response to surgical pain on several occasions 
after attempts to decrease the infusion rate. Breath holding was observed in 
one case in the HH group. There was no significant difference in the other 
respiratory side effects. Involuntary movements were noted in the three 
groups using an intravenous agent (PP, PH, and TH), and were more 
frequent with propofol than with thiopentone (p=O.OOl). This occurred in 13 
patients (34.2%) in group PP, 19 patients (45.2%) in group PH, nine patients 
(23.0%) in group TH, and none in group HH. 
Intraoperatively, respiratory complications were more common in 
group PP. In the child who desaturated, this was related to the apnoeic 
spells and the patient's lungs had to be hand-ventilated most of the time. 
Arrhythmias were noted in groups TH and HH but none occurred in 
propofol groups (Table 8.2). However none of these complications was 
serious enough to interfere with the progress of surgery. 
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Apnoea> 20s 18** 
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Laryngeal spasm 1 
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TABLE 8.3. Recovery times from the end of anaesthesia for various objectives 
(mean (SD)) 




























Recovery times of the four groups are shown in Table 8.3. After 
operation, children in group pp were slower to wake up. Times from the end 
of anaesthesia to achieving all recovery objectives (full Steward score, open 
eyes on command, and orientation in name and age) were significantly 
longer for the group pp compared with those for the other three groups (p= 
0.0001). Recovery times in the groups PH, TH, and HH were similar. In 
group PP, the calculated mean propofol concentration at the end of infusion 
and anaesthesia was 4.9 (range 2.5 to 8.0) Jlg.ml-1, and at the time of opening 
eyes on command was 0.97 (range 0.4 to 1.9) Jlg.ml-1, and at the time of 
orientation was 0.9 (range 0.5 to 1.5) Jlg.ml-l . 
The mean times taken to perform the puzzle before operation were 
similar in the four groups (p=0.85l). After anaesthesia, there was 
impairment in psychomotor performance in all four groups, and the times 
taken to complete the puzzle at all time points were significantly longer than 
before operation (p=O.OOOl). The performance by group PP was the worst in 
terms of the number of patients who were able to do the puzzle and the time 
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required to complete the task at 0.5 hour (p=O.OOOl) and at 1 hour (p=0.024) 
after anaesthesia. Group PH scored best, but not significantly better than 
groups TH and HH. Although the difference between all four groups had 
disappeared by two hour time, there was still 22-28% impairment in 
performance compared to baseline (Table 8.4). 
TABLE 8.4. Psychomotor test: preoperative and the postoperative times required 
to perform the puzzle (mean (SD)) 
Preoperative 
Time required (s) 
0.5 h after anaesthesia 
0/0 of children able to 
perform test 
Time required (s) 
1 h after anaesthesia 
0/0 of children able to 
perform test 
Time required (s) 
2 h after anaesthesia 
0/0 of children able to 
perform test 
Time required (s) 





































The postoperative side effects are listed in Table 8.5. Group PH had 
the least problems. The incidence of restlessness and disorientation was 
greater in group PP. More children in groups TH and HH complained of 
giddiness. The incidence of nausea and vomiting was zero in the PP group 
and greatest in group HH with groups PH and TH intermediate. Statistical 
analysis was not carried out on side effects as their incidence was too small. 
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A comparison of anaesthetic techniques should be performed ideally 
with a similar level of anaesthesia. However, there are still many limitations 
to the objective monitoring of central nervous system sedation especially in 
paediatric practice. The criteria used in this study were the standard clinical 
criteria similarly used in other paediatric studies to maintain a comparable 
level of anaesthesia between the groups [Martin, Nicolson, and Bargas, 1993; 
Hannallah et aI, 1994] " 
In group PP, an initial blood target propofol concentration of 8 J.1g.ml-
1 was set for induction of anaesthesia. This was based on the findings 
(concentration range of 5-13 J.1g.ml-1) from the pilot study of 10 cases in the 
pharmacokinetic-model-controlled infusion study (page 111). The quality of 
induction was not different from the other three groups (p=0.114). 
Respiratory side effects were more frequent in group PP during induction as 
well as during operation. This may be due to the difficulty in maintaining an 
optimum level of anaesthesia with a new technique. The use of propofol 
infusion for maintenance of anaesthesia is still new in paediatric practice. 
The incidence of pain" on injection in this study is smaller than that in the 
dose requirement study (page 52) suggesting that the lignocaine dose used in 
this study (0.2 mg.kg-1) is more effective than the dose used in that study 
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(0.15 mg per 3 mg of propofol). Dose of 0.2 mg.kg-1 lignocaine is the 
minimum effective dose recommended [Morton et aI, 1992]. The incidence of 
involuntary movements following propofol induction (35% in pp to 45% in 
PH) was more frequent compared with thiopentone induction (23%). 
However these were transient and did not disrupt the surgical procedure. 
The absence of arrthymias in groups PP and PH is encouraging. However 
the sample studied is probably not large enough to make any definite 
conclusion on this finding. 
Recovery was significantly slower in group PP compared with the 
other three groups. The children took twice as long to achieve the recovery 
objectives (Table 8.3). This was both statistically and clinically significant. 
This finding is in contrast to the other paediatric studies [Puttick and Rosen, 
1988; Borgeat et aI, 1990; Doyle, McFadzean, and Morton, 1993; Martin, 
Nicolson, and Bargas, 1993; Hannallah et aI, 1994]. Puttick and Rosen [1988] 
and Borgeat and associates [1990] observed a faster recovery following 
propofol anaesthesia compared with thiopentone induction and halothane 
maintenance in dental and ENT patients respectively. Martin and colleagues 
[1993] and Hannallah and coworkers [1994] reported no difference in the 
recovery time after anaesthesia with total propofol anaesthesia compared 
with the other anaesthetic techniques used in their studies. However the 
methodology used in these studies were different from the current study. In 
the studies by Martin and colleagues [1993] and Borgeat and associates 
[1990], patients' lungs were ventilated after neuromuscular blockade. 
Patients in Hannallah's study [1994] had their trachea intubated and some 
had non-depolarising neuromuscular blockade during the procedure. 
Puttick and Rosen [1988] used intermittent boluses of propofol during 
maintenance of anaesthesia and the duration of the procedures was less than 
10 minutes. The propofol infusion technique used by Doyle, McFadzean, and 
Morton [1993] was remarkably similar to that in group PP in this study 
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except for the difference in pharmacokinetic model used. They observed no 
difference in the recovery times after anaesthesia using either propofol 
infusion or propofol bolus followed by maintenance with halothane. In 
contrast, the propofol infusion group in this study took twice as long as the 
propofol bolus group to recover. 
In the study by Doyle and colleagues [1993], the initial target blood 
concentration of propofol set at induction was in the range of 8-14 Jlg.ml-1, 
and the concentration in this study was set at 8 Jlg.ml-1 and then adjusted 
accordingly. The mean total dose used in their infusion group was 17.9 
(range 4.8-28.3) mg.kg -1 [Morton-personal communication] which was 
similar to the 17.1 (range 10-31.9) mg.kg -1 used in group pp in this study. 
Their mean target blood concentration at the end of anaesthesia was 5.8 
(range 4-10) Jlg.ml-1 [Morton-personal communication] which was slightly 
greater than the concentration of 4.9 (range 2.5-8) Jlg.ml -1 in the present 
study. The estimated blood propofol concentration at the time when their 
patients woke up was 1.4 (range 0.3-2.6) Jlg.ml -1. This was again slightly 
greater than that in this study (0.97 (range 0.4-1.9) Jlg.ml -1). The patients in 
the pp group of this study required 39.8 (range 15-70) min to open their eyes 
on command whereas the children in the study by Doyle and colleagues 
required only 13.5 (range 4-36) min to wake up and open their eyes 
spontaneously [1993]. The pharmacokinetic model developed for the local 
Chinese children had a 250/0 larger volume of distribution than the model 
developed in Glasgow [Marsh et aI, 1991]. This indicates that patients in the 
current study were maintained at lower plasma concentrations than the 
patients in the study by Doyle and colleagues [1993]. Therefore, the 
difference in recovery was not caused by excessive doses of propofol being 
given to patients in the present study. However the difference in recovery 
time cannot be fully explained by the pharmacokinetic differences between 
the two groups and it is possible that there is an ethnic difference in the 
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pharmacodynamic profile of the drug in the two populations. This 
suggestion is supported by the longer time required by the patients in this 
study to recover following propofol induction and halothane maintenance 
(21.9 min) compared with those patients who had a similar anaesthetic in the 
study by Doyle and colleagues (10.5 min) [1993]. It is worth noting that 
delayed recovery has been listed as one of the neurological dysfunction 
reported after the use of propofol [Committee on Safety of Medicines, 1989] 
In an open study of propofol infusion study in Belgium 
[Vandermeersch et aI, 1989], recovery was also slow - mean time to open eyes 
after termination of infusion was 39.5 (SD 12.6) minutes. The mean 
concentration at the time of awakening was 2.3 ~g.ml-1. This may be related 
to the difference in the anaesthetic technique used. The patients were 
heavily premedicated with morphine and hyoscine and intraoperatively, 
fentanyl was given and the propofol infusion was given at a constant rate of 
12 mg. kg.-1h-1 until the end of the procedure. 
The three conventional techniques, propofol, thiopentone or halothane 
induction followed by maintenance with halothane maintenance (groups TH, 
PH, and HH) had similar recovery characteristics. Recovery appeared to be 
more dependent on the maintenance agent rather than the induction agent as 
has been previously observed by Runcie and colleagues [1993] with 
anaesthesia over 30 minutes duration. 
Psychomotor performance using the time to complete a simple puzzle 
was included in the assessment to compare the recovery of co-ordination 
ability. Recovery of psychomotor performance in children who had had 
propofol infusion was significantly slower than those who had had propofol, 
thiopentone or halothane for induction and maintenance with halothane. 
Psychomotor tests have not been commonly used in paediatric studies. In 
this study, they were found to be easy to perform and they discriminate 
between degrees of sedation better than simple tests based on the state of 
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consciousness. The psychomotor recovery appeared comparable to previous 
adult studies [Gregory et aI, 1990], indicating that recovery from anaesthesia 
is no faster in children. The children who had had propofol for anaesthesia 
had a lesser incidence of emesis than those who had had halothane. Many 
recent studies have noted this similar feature with propofol anaesthesia 
[Watcha et aI, 1991; Larsson, Asgeirsson and Magnusson, 1992; Martin, 
Nicolson and Basgas, 1993; Snellen, Vanacker and Van Aken, 1993; Weir et aI, 
1993; Hannallah et aI, 1994] They were less giddy and drowsy but notably 
more children were restless and at times, it was difficult to comfort them. 
This is similar to the finding by Larsson and colleagues [1992]. 
In summary, propofol for induction and maintenance of anaesthesia 
supplemented with nitrous oxide and regional block was unsatisfactory in an 
unpremedicated local Chinese paediatric population. It was associated with 
a delayed early recovery postoperatively compared with induction of 
anaesthesia using propofol, thiopentone or halothane and maintenance with 
halothane. The recovery profiles were similar in the three groups. However, 
further modification of the infusion and anaesthetic technique and 
evaluation is necessary before the place of propofol infusion in paediatric 
anaesthesia can be determined. 
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CHAPTER 9 
Summary 
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SUMMARY 
The objective of this thesis was to evaluate the use of propofol in 
paediatric anaesthesia. The hypothesis that propofol is an effective 
intravenous anaesthetic agent for induction and maintenance of anaesthesia 
for short surgical procedures in children was tested. 
Pharmacology 
Propofol (2,6 diisopropyl phenol) in its new emulsion formulation 
was introduced to clinical anaesthesia in 1983 for trial purposes. It is an 
alkylphenol with anaesthetic properties and it is virtually insoluble in water. 
It was originally solubilized in Cremophor EL, but the association of this 
solubilizing agent with anaphylactoid reactions led to its withdrawal. The 
currently available preparation is a 10/0 w Iv in aqueous emulsion containing 
10% w Iv soybean oil, 1.20/0 w Iv egg phosphatide and 2.25% w Iv glycerol. 
The potency of this formulation is slightly less than the Cremophor 
formulation (AD95 of 2.5 mg.kg-1 vs 2.0 mg.kg-1 respectively). 
Clinical pharmacology 
The pharmacokinetic profile of propofol can be described by three 
exponential functions. A fast distribution from blood to well perfused 
tissues (a half-life of 2-3 min), a rapid metabolic clearance (B half-life of 0.5-1 
h), and a slow return of propofol from the poorly perfused compartment (y 
half-life of 4-11 h). The estimated central volume of distribution is large (0.3-
0.5l.kg-1). The apparent volume of distribution is two to three times as large 
as the volume at steady state resulting· in a very long terminal half-life. 
Protein binding is 97-99%. Generally clearance exceeds the estimated hepatic 
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blood flow suggesting that extrahepatic mechanisms contribute to its 
clearance. 
In healthy adults, bolus doses in the range of 2.0-2.5 mg.kg-1 are 
required for induction of anaesthesia depending on the premedication. It 
has a rapid but variable onset of action (range 22-125 s). The rapid 
distribution and elimination contribute to its short duration of action. 
Recovery occurs 15 - 20 minutes after a single induction dose of propofol and 
is quicker than after thiopentone. A long terminal half-life indicates that 
propofol might accumulate when it is administered either by repeated bolus 
injections or constant rate infusion for anaesthesia or sedation. It is currently 
the intravenous agent of choice as the hypnotic component of total 
intravenous anaesthesia. Induction of anaesthesia is usually associated with 
pain on injection and a few excitatory effects. The depression of the 
cardiovascular system with propofol is more than with an equipotent dose of 
thiopentone. The decrease in arterial pressure is approximately 30% after 
induction with propofol. The baroreflex is reset to allow a slower heart rate 
despite a decrease in arterial pressure. Respiratory depression foHowing 
propofol induction is common. The upper airway reflexes are more 
suppressed than after thiopentone. The incidence of postoperative vomiting 
is so low that it is suggested that propofol has an antiemetic effect. 
Clinical Studies 
Induction of anaesthesia - Dose requirements 
Studies have shown that children require a larger dose of propofol for 
induction of anaesthesia than adult patients. · The data were mostly from 
children above three years old. The induction dose required in children was 
determined by a quantal dose-response study of 300 unpremedicated healthy 
children divided into three age groups: less than two year old, two to five 
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years old and six to 12 years old. The ED50 and ED95 for loss of eyelash 
reflex and acceptance of a facemask were largest in the group less than two 
years old, smaller in the group two to five years old and smallest in the 
group six to 12 years old. The acceptance of facemask was considered to be a 
satisfactory indicator for smooth transition to maintenance of anaesthesia 
using inhalational anaesthetic agents. The ED95 for this endpoint in the 
three-age groups in ascending order were 2.88, 2.53, and 2.20 mg.kg-1 
respectively. The recommended dose for induction in unpremedicated 
children is in the range of 2.5 to 3.5 mg.kg-1, the higher dose range being for 
younger children with decreasing requirements as the age increases. The 
induction dose required in children is larger than the dose required for 
adults (2.0-2.5 mg.kg-1 ). 
Induction characteristics - Haemodynamic response 
Induction of anaesthesia with propofol has been shown to cause a 
significant reduction in arterial pressure which was greater than that after 
thiopentone both in children and in adults. The haemodynamic response to 
propofol was studied in two studies to examine dose-related changes and the 
mechanism for the hypotension during induction. The arterial pressure and 
pulse rate changes in response to different induction doses of propofol were 
studied in 216 patients from the dose-finding study. The doses studied were 
1.6, 1.8, 2.0, 2.2, 2.4, and 2.6 mg.kg- 1. The mean reduction in arterial 
pressures was 15% over the first minute and 30% at five minutes after 
propofo!. The mean reduction in pulse rate was 17%. The reduction in 
arterial pressures and pulse rate were not dose-related. This is different from 
that observed in adults, but the reason is not clear. 
The mechanism for the hypotension following propofol was 
compared with that after thiopentone using the technique of pulsed Doppler 
echocardiography in two age-groups of children. Intravenous induction of 
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anaesthesia in children uSIng propofol was found to cause more 
cardiovascular depression than that after an equipotent dose of thiopentone. 
After propofol, the cardiac index was reduced by 10-15% and systemic 
vascular resistance by 15-19%. The heart rate in younger children was 
reduced significantly (24%) but remained unchanged in the older children. 
The baroreceptor reflex appeared to be impaired more in younger children 
than in older children. This degree of cardiovascular depression is of no 
clinical significance in healthy children, but potentially dangerous in patients 
with a compromised circulatory function. 
Induction characteristics - Other effects 
The incidence of pain on injection was variable and not dose-related. 
When 0.15 mg of lignocaine was mixed with each 3 mg of propofol before 
injection in the dose finding study, pain on injection was observed in 0 - 43% 
of children less than two years old, 9 - 33% of children between two and five 
years old, and 8 - 35% of children between six and twelve years old. The 
incidence was reduced to 14 - 18% when 0.2 mg.kg-1 of lignocaine was given 
intravenously just before administration of propofol in the study comparing 
four techniques of anaesthesia. 
The incidence of apnoea was dose related, and also appeared to be age 
related. Using different doses of propofol in the dose finding study, apnoea 
occurred in 0 - 290/0 of children less than two years old, 0 - 420/0 of children 
between two and five years old and 6 - 53% of children between six and 
twelve years old. 
The incidence of involuntary movements was high, 44% in children 
less than two years old, 550/0 in children between two and five years old and 
47% in those between-six and 12 years old. However, they were short-lived 
and did not disrupt the conduct of anaesthesia and surgery. 
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Single dose pharmacokinetics 
Physiological changes in distribution of body water, cardiovascular, 
hepatic, and renal function during childhood may affect the distribution, 
metabolism and excretion of drugs. Pharmacokinetics after a single 
intravenous dose of propofol were studied in 23 children aged between one 
and 12 years old. There was a large interindividual variation in the 
pharmacokinetic variables. The mean central volume of distribution was 
0.66 (SD 0.23) l.kg-1, the mean volume of distribution at steady state was 4.40 
(SD 1.78) l.kg-1, and clearance 49.96 (SD 20.2) ml.min-1.kg-1. There was a 
good correlation between the body weight and the values of central volume 
of distribution, volume of distribution at steady state and clearance, but no 
significant correlation was found between age and any of the 
pharmacokinetic variables. There was no difference in the protein binding of 
propofol between children less than three years old and those over ( 98.8% vs 
98.6%). This implies that the difference in the propofol dose required for 
induction of anaesthesia in different age groups of children is not due to age-
related differences in pharmacokinetics. The differences may be 
pharmacodynamic in origin. The central nervous system may have a 
different sen,sitivity to anaesthetic agents at different ages. The fact that there 
is no age-related difference in propofol pharmacokinetic variables from one 
to 12 years old suggests that the same algorithm can be used for infusion in 
children within this age range. However, the infusion rate should be titrated 
against clinical effects because target-concentrations required vary between 
individuals. 
Maintenance of anaesthesia - infusion pharmacokinetics 
Compared with thiopentone, propofol has a suitable pharmacokinetic 
and pharmacodynamic profile for maintenance of anaesthesia by infusion. 
Infusion of intravenous agents has been simplified by the availability of 
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computer-controlled infusion pumps controlled by.pharmacokinetic models. 
The use of a published algorithm for administering propofol to paediatric 
patients was prospectively tested in 10 Chinese patients between four and 10 
years old. The precision of the model was 24.8% and bias -18.5%. A revised 
pharmacokinetic algorithm for this population was developed after iterative 
linear least squares regression procedure. The revised pharmacokinetic 
algorithm which had a theoretical precision of 23.1 % and. bias of -0.3% was 
evaluated in another sample of 20 paediatric patients. The precision was 
21.5% and bias -0.1%. The mean target concentrations of propofol were 5-13 
J..Lg. ml-1. Further iterative linear least squares regression of the 
pharmacokinetic variables did not result in a further theoretical 
improvement in bias or precision of the model. 
Anaesthesia using propofol infusion for induction and maintenance of 
anaesthesia by this infusion system was compared with three standard 
techniques of anaesthesia: propofol, thiopentone or halothane for induction 
followed by halothane for maintenance in 163 healthy children undergoing 
minor body surface procedures. All patients breathed 70% nitrous oxide in 
oxygen spontaneously. Duration of anaesthesia was about half an hour 
duration. In the propofol infusion group, the mean induction dose of 
" 
propofol during induction was 3.5 mg.kg-1 and the mean infusion rate was 
27.3 (SD 8.1) mg.kg.-1h-1. The mean ipduction dose of propofol was 2.9 
mg.kg-1 in the propofol bolus group, and the induction dose in the 
thiopentone group was 4.7 mg.kg-1. Analgesia was provided by an 
appropriate regional block. The quality of anaesthetic induction, as graded 
by the anaesthetist, was similar in the four techniques. Apnoea was more 
frequent with the propofol infusion method than the other three methods of 
anaesthesia. There was no significant difference in the incidence of other 
respiratory side effects. Involuntary movements were noted in the patients 
having intravenous agents. These were more frequent with propofol than 
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with thiopentone. Arrhythmias were seen in patients receiving thiopentone 
and halothane but none were seen in those who had had propofol for 
anaesthesia. However, none of these complications was serious enough to 
interfere with the progress of surgery. The higher incidence of respiratory 
complications in the propofol infusion anaesthesia was probably due to the 
difficulty in maintaining an optimum level of anaesthesia with a new 
technique of anaesthesia. 
Recovery 
Recovery characteristics were assessed in the same 163 patients, based 
on the time from the end of anaesthesia to (1) achieve a full Steward score 
which included three categories of assessment: level of consciousness, airway 
control, and movement, (2) open eyes on command, and (3) orientation to 
name and answering simple questions such as age. Psychomotor 
performance was also included in the assessment to compare the recovery of 
co-ordination ability. Recovery was slowest with propofol infusion. 
However, children who had propofol anaesthesia (bolus as well as infusion) 
felt less giddy than those children who had had thiopentone and halothane 
anaesthesia, and they had less postoperative vomiting. The recovery profiles 
were similar in the three techniques using propofol bolus or thiopentone or 
halothane for induction and halothane maintenance. 
Modification of the total intravenous anaesthetic technique, such as 
using supplementary opioids to suppress the response to noxious 
stimulation, and further evaluation is needed before the place of propofol 
infusion in paediatric anaesthesia can be determined. 
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CHAPTER 10 
Conclusions 
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CONCLUSIONS 
Induction 
Propofol, in doses of 2.5 to 3.5 mg.kg-1, is a satisfactory agent for induction 
of anaesthesia in unpremedicated children. Younger children need more 
than older children within this dose range. 
Induction of anaesthesia uSIng propofol causes more cardiovascular 
depression than after an equipotent dose of thiopentone. Arterial pressure is 
reduced by 30% , and is associated with a reduction in cardiac index and 
systemic vascular resistance. Compensation by the baroreflex appears to be 
impaired more in children less than two years old. This degree of 
cardiovascular depression is well tolerated in healthy children, but 
potentially harmful in those with a compromised cardiovascular function. 
The pharmacokinetic variables after a single dose (2.5 mg.kg-1) of propofol 
have a good correlation with body weight, but not with the age of the 
patients after the pharmacokinetic variables were adjusted for the body 
weight. Th~re was no difference in protein binding of propofol between 
younger and older children. These imply that the difference in the dose 
required for induction of anaesthesia in different age groups of children is 
not due to pharmacokinetic differences, although differences in 
pharmacodynamics cannot be excluded. 
Maintenance 
Pharmacokinetic-model-controlled infusion of propofol for maintenance of 
anaesthesia is easy and reliable to use in children provided that the 
pharmacokinetic parameters are accurate. A revised version was developed 
from a published model. The precision was 21.5% and the bias -0.1%. 
Summary and Conclusions 158 
Compared with thiopentone and halothane, propofol anaesthesia was 
associated with more pain on injection, involuntary movements, respiratory 
side effects, but fewer arrthymias during the procedure. 
Recovery 
Recovery following anaesthesia using propofol infusion was slower than that 
following propofol given as bolus dose and maintenance with halothane. 
Similarly, it was slower than that after thiopentone or halothane induction 
and maintenance with halothane. Differences between the latter three 
techniques were not significant. Propofol anaesthesia was associated with 
less vomiting and giddiness after the operation. 
Conclusion 
This thesis evaluated the use of propofol for anaesthesia in children 
undergoing short surgical procedures. It upheld the hypothesis that 
propofol is an effective induction agent in paediatric anaesthesia. However, 
the place of propofol infusion for maintenance needs further modification 
and evaluation before it can be accepted as an alternative to existing 
techniques. As this agent is still relatively new at this stage, it should be 
used with care. Any adverse reactions should be reported to the local 
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CALIBRATION DATA OF PROPOFOL 
Chapter 2: Methods 
Interassay variation of propofol ( mean of 3 for each point) 
Propofol Peak height ratio n Mean SD CV 
cone Propofol / Internal standard 
ng.ml-1 (n= 3) 
1 2 3 4 5 6 7 
50 0.110 0.110 0.110 0.120 0.100 0.100 0.112 7 0.109 0.007 6.43 
100 0.230 0.210 0.210 0.200 0.230 0.210 0.211 7 0.215 0.011 5.25 
250 0.410 0.440 0.460 0.510 0.530 0.540 0.518 7 0.487 0.050 10.27 
500 0.950 0.970 0.950 0.940 0.990 1.010 1.069 7 0.983 0.045 4.62 
1000 2.240 2.030 1.980 1.920 2.130 2.230 2.399 7 2.133 0.169 7.94 
3000 6.240 5.850 6.700 5.930 6.030 5.820 6.444 7 6.145 0.331 5.39 
Intra-assay variation (n=3) 
Propofol Peak height ratio Mean SD CV 
cone Propofol/Internal 
ng.ml-1 standard 
1 2 3 
50 0.104 0.127 0.121 0.120 0.010 9.96 
100 0.199 0.209 0.207 0.210 0.010 2.64 
250 0.473 0.515 0.529 0.510 0.030 5.77 
500 0.936 0.968 0.929 0.940 0.020 2.19 
1000 1.919 1.865 1.997 1.920 0.050 2.65 
3000 5.931 6.031 5.817 5.930 0.110 1.81 
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Ex of thyroglossal cyst 
























































Bil. tll:~rniotomy N 
Herniotomy N 
HLPPV N 
Revision of scar Y 
Herniotomy N 
Herniotomy & circumcisioll N 
Herniotorny N 
HerniotOJTlY N 
Hypospadias repair N 
Herniotomy & circumcisioll N 






Orthopaed ic N 
Herniolomy N 
Excision of scalp lesion Y 
Pyeloplasty Y 
Herniotomy Y 
Closure of colostomy Y 
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Reimplantation of ureters 
Excision of cyst 
Herniotorny 









Ci rcu rncision 
Herniotomy 









Exploration of toe 
Ci (eu meision 






Cleft pal a le repair 
OrChidopexy 
Herniotorny 
Removal of ear wax 
Orchido~xy 
Drainage of abscess 
Excision of allricle 
Herniotomy 
Herniotomy 












Ci reu mcision 
Orthopaedic 
Excision of skin lurnp 
Orchinopexy 
Ci rell mcision 
Herniotomy 
Ortl,opaedic 
Ligation of varicocoele 







































































































































































































Apnoec Duration Involuntary 
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Circumcision Y . 
Repair of vaginal fistula N 




Orthopaed ic Y 
Circumcision N 




Hypospadias repair N 
Excision of cyst N 
Circumcision N 
Hemiotomy Y 
Orthopaerl ic Y 
Circumcision N 
OrthopaL>d ic N 
Excision uf mole N 
Cin'umcision N 
Turhinectomy N 
Ex of prt'auricular sinus N 
Ex of duplex kidney N 
Excision of cyst N 
Orthopaed ic N 
Herniotomy 
Excision of lipoma Y 
Orchidopexy Y 
Herniotomy Y 
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Orthopaed ic N 




Penile chordae N 
Herniotomy N 






Orthopaed ic Y 
Orchidopexy Y 
Excision of auricle Y 
Anoplasty Y 
Division of tongue tie Y 
Anoplasty N 
Herniotomy N 
Ex of preauricular sinus Y 





Ex preauricular sinus N 
Herniotorny Y 
Circumcision N 
Excision of mole N 
Excision of haemangioma N 
Circumcision N 
Herniotomy . N 










Excision of cyst N 
Excision of lipoma N 
Hypospadias repair N 








Orthopaed ic Y 
Pull through Y 
Orchidopexy Y 
Excision of cyst N 
Division of tongue tie Y 
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Age Sex B.wt Dose Propofol Surgery 
group dose 


























































































Excision of mole 
HLPPV 
Excision of sinus 
Herniotomy 
Herniotomy 






Excision of cyst 
Circumcision 





Excision of colonic polyp 
Circumcision 
Ci rcu mcision 
Circumcision 
Excision of colonic polyp 
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~ '1j ('t) ::s 0- ~. () ('t) Ul N ~ o 
Chapter 6: Single dose pharmacokinetics 
Protein concentration and binding data 
Appendices 211 


































(yr) . (kg) 
M 1.0 <3 yr 11.8 
M 1.0 <3 yr 10.9 
M 1.3 <3 yr 11.8 
M 1.7 <3 yr 11.7 
M 2.0 <3 yr 12.5 
M 2.0 <3 yr 12.4 
F 2.0 <3 yr 9.9 
M 2.2 <3 yr 13.9 
M 2.9 <3 yr 14.6 
M 3.0 <3 yr 14.5 
M 3.0 <3 yr 13.4 
M 3.0 <3 yr 16.7 
M 
F 
3.5 3-12yr 12.9 
3.5 3-12yr 15.2 
M 4.2 3-12yr 15.7 
M 8.0 3-12yr 27.0 
F 10.0 3-12yr 31.2 
M 11.0 3-12yr 39.5 
M 11.0 3-12yr 50.9 
M 11.0 3-12yr 36.0 
M 12.0 3-12yr 30.0 
M 12.0 3-12yr 38.0 
M 21.0 ad 64.0 
M 25.0 ad 
M 26.0 ad 
M 27.0 ad 
M 28.0 ad 
M 31.0 ad 
M 32.0 ad 
M 35.0 ad 
M 37.0 ad 
M 30.0 ad 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 7: P1Ulr7nacokinetic model controlled infusion of propofol 
Individual patient data (part 11 study). 
P(rn) Propofol concentration measured, P(p) propofol concentration predicted, 
Pred er% = prediction error%, Abs pred er% = absolute prediction error% 
Appendices 213 








duration (sampling) (maintl ()Jg.ml-l) ()Jg.ml-l) er% pred er% bias % prec % (awake) 
(yr) (kg) (min) (rnin 1l."C) 
after inc1) 
16.7 18 
6 20.3 26 
9 33.0 47 
10 25.0 56 
8 18.8 20 
5 I1t8 36 

































































































































































Rec 0.87 0.73 
Maint to.98 10.00 
Maint 9.96 to. 00 
Ma int 8.02 8.00 
Maint 6.02 6.74 
Rec 4.60 5.38 
Rec 2.95 - 3.91 
















-8.18 8.18 -14.78 
-2.29 2.29 -8.89 
-9.37 9.37 -15.97 
-24.02 24 .02 
11.84 11.84 1.84 
-1.58 1.58 -11.58 
-18.39 18.39 -28.39 
15.62 15.62 5.62 
10.84 to.84 0.84 
-4.57 4.57 -14.57 
36.42 36.42 26.42 




-15.49 15.49 -19.59 
7.95 7.95 3.85 
28.23 28.23 24 .13 
15.53 15.53 11.43 






























































































Chapter 7: Plwrmacokinetic 7nodeI controlled infusion of propofoI 
Individual patient data (part 11 study) (continued) 
P(m) Propofol concentration measured, P(p) propofol concentration predicted, 
Pred er% = prediction error%, Abs pred er% = absolute prediction error% 
Appendices 214 








duration (sampling) (maint/ ijJg.ml-l) ijJg.ml-l) er% pred er% bias % prec % (awake) 
(yr) (kg) (min) (min ree) 
after ind) 
6 19.4 35 
6 24.5 23 
4 16.5 23 
9 29.7 19 
4 153 24 
9 23.3 33 















































































































































































44.63 44.63 14,43 
33.62 33.62 3.42 
33.18 33.18 298 
9.56 9.56 -20.64 
48.95 48.95 18.75 





13.88 13.88 21.68 
-1.23 l.23 6.57 
-9.36 9.36 -1.56 




-17 .2~ 17 . 2~ 
-23.50 23.50 
9.04 9.04 -5,41 
36.35 36.35 21.90 
21.62 21.62 7.17 





23.47 23 .47 6.37 
13.22 13.22 -3.88 





14 .91 14 .91 
10.D1 10.01 29.55 
-5.92 5.92 13.62 
-19.75 19.75 -0.21 
-33.73 33.73 -14.19 
-48,4148.41 -28.87 
-13.94 13.94 -2.24 
-2.53 2.53 9.17 
3.94 3.94 15.64 
-3.79 3.79 7.91 
-18.78 18.78 -7.08 





12.99 12.99 24 .09 
38.91 38.91 50.01 
-27,44 27.44 -16.34 
-34 .96 34 .96 -23.86 













































Chapter 7: Pharmacokinetic model controlled infusion of propofol 
Individual patient data (part Il study) (continued) 
P(m) Propofol concentration measured, P(p) propofol concentration predicted, 
Pred er% = prediction error%, Abs pred er% = absolute prediction error% 
Appendices 215 
No Patient Age Weight lnftLc;ion Time Phase P(rn) P(p) Pred Abs Individual Individual Pred conc 
duration (sampling) (maint/ ()Jg.ml-l) (JJg.ml-l) er% pred er"!'. bias % prec % (awake) 
(yr) (kg) (min) (min ree) 
after ind) 
15 CKK 9 43.7 52 
16 LYS 4 16.3 40 
17 LHY 5 19.6 29 
18 PKS 6 23.6 24 
19 WKM 9 39.0 41 











































































































































































































































-7 .44 7.44 
-28.10 2lUO 
-43.74 43 .74 
-33.54 33.54 























































































Chapter 8: Comparison of anaesthesia and recovery of four anaesthetic techniques 
Anaesthesia data (PP group) 
















































































































































Ci rcu mcision 
Circumcision 











Cystoscopy & biopsy 
Cystoscopy 
Circumcision 
Repair buried penis 
Ex cyst on penis 
Circumcision 






























































































































































Y (20S) N 
N N 
Y (30S) Y 
Y (40S) Y 
Y(20S) N 
Y (205) N 
Y (155) N 





































































Chapter 8: Comparison of anaesthesia and recovery of four anaesthetic techniques 
Anaesthesia dnta (PH group) 
Patient Age Sex 
no 
(rr) 
145 7 F 
45 10 F 
47 10 M 
49 10 M 
24 5 M 
29 11 M 
41 9 F 
148 8 M 
23 4 M 
100 7 F 
65 10 M 
116 6 M 
S9 9 M 
143 9 M 
149 7 M 
101 9 M 
157 6 M 
64 8 M 
68 4 M 
140 3 M 
102 5 M 
74 4 F 
69 4 M 
35 4 M 
87 10 M 
72 4 M 
104 4 F 
78 6 M 
99 6 F 
77 4 M 
32 11 F 
109 5 M 
110 5 M 
175 5 M 
53 12 M 
84 10 F 
81 8 F 
91 7 M 
174 10 M 
20 4 M 
173 4 M 




























































Ex cyst glans penis 
Cir & herniotomy 
Ci rcu mcision 
HLPPV 
Circumcision 
Cir & ureth dilatation 
Ex alopecia 
Circumcision 





Ex Larm lump 
H yd rocoeele 




















































































































































Y (205) Y 
N Y 
Y (105) Y 
N Y 
N Y 












































































Chapter 8: Comparison ot anaesthesia and recovery of four anaesthetic techniques 
Anaesthesia tinta (TH group) 
































































































































Ex L thigh nodule 
Circumcision 
Herniotomy 
LIH & circumcision 




Ci rcu mcision 
























































































































































Y (155) Y 
N N 
N Y 
Y (105) N 
N N 
N N 
Y (205) N 
N N 
N N 
Y (155) N 
N N 
N N 






























































Chapter 8: Comparison of anaesthesia and recovery of four anaesthetic techniques 
Anaesthesia data (HH group) 



















































































































































Ex periurethral wart 
Circumcision 
Release L trigg. thumb 
Orcumcision 
Circumcision 









Induction Propafol Total Anaes Pain Apnoea Involuntary Anaes duration 
dose 
(mg) 
































































































































































Chapter 8: COlnparison of anaesthesia and recovery of four anaesthetic techniques 
Recovery data (PP group) 
Patient Croup Time to Time to Time to Psychomotor performance 





























































































































































































































































































































Chapter 8: C01nparison of anaesthesia and recovery of four anaesthetic techniques 
Recovery data (PH group) 
Patient Group Time to Time to 
no full open eye 
































































































































Time to Psychomotor performance 






























































































































































































































Chapter 8: C07nparison of anaesthesia and recovenJ of four anaesthetic techniques 
Recovery data (rH group) 
Patient Group Time to Time to Time to Psychomotor performance 





































































































































































































































































































































Chapter 8: C01nparison of anaesthesia and recove11j of four anaesthetic techniques 
Recovery data (HH group) 
Patient Group Time to Time to Time to Psychomotor performance 








































Steward score on command 
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